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ABSTRACT  
   
The current study utilized data from two longitudinal samples to test mechanisms 
in the relation between a polygenic risk score indexing serotonin functioning and alcohol 
use in adolescence. Specifically, this study tested whether individuals with lower levels 
of serotonin functioning as indexed by a polygenic risk score were vulnerable to poorer 
self-regulation, and whether poorer self-regulation subsequently predicted the divergent 
outcomes of depressive symptoms and aggressive/antisocial behaviors. This study then 
examined whether depressive symptoms and aggressive/antisocial behaviors conferred 
risk for later alcohol use in adolescence, and whether polygenic risk and effortful control 
had direct effects on alcohol use that were not mediated through problem behaviors. 
Finally, the study examined the potential moderating role of gender in these pathways to 
alcohol use. 
 Structural equation modeling was used to test hypotheses. Results from an 
independent genome-wide association study of 5-hydroxyindoleacetic acid in the 
cerebrospinal fluid were used to create serotonin (5-HT) polygenic risk scores, wherein 
higher scores reflected lower levels of 5-HT functioning. Data from three time points 
were drawn from each sample, and all paths were prospective. Findings suggested that 5-
HT polygenic risk did not predict self-regulatory constructs. However, 5-HT polygenic 
risk did predict the divergent outcomes of depression and aggression/antisociality, such 
that higher levels of 5-HT polygenic risk predicted greater levels of depression and 
aggression/antisociality. Results most clearly supported adolescents’ 
aggression/antisociality as a mechanism in the relation between 5-HT polygenic risk and 
later alcohol use. Deficits in self-regulation also predicted depression and 
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aggression/antisociality, and indirectly predicted alcohol use through 
aggression/antisociality. These pathways to alcohol use might be the most salient for 
boys with low levels of socioeconomic status.  
Results are novel contributions to the literature. The previously observed 
association between serotonin functioning and alcohol use might be due, in part, to the 
fact that individuals with lower levels of serotonin functioning are predisposed towards 
developing earlier aggression/antisociality. Results did not support the hypothesis that 
serotonin functioning predisposes individuals to deficits in self-regulatory abilities. 
Findings extend previous research by suggesting that serotonin functioning and self-
regulation might be transdiagnostic risk factors for many types of psychopathology.  
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Serotonin Functioning and Adolescents’ Alcohol Use: 
A Genetically Informed Study Examining Mechanisms of Risk 
Alcohol use among adolescents and young adults is a major public health 
concern. Alcohol use and disorder increase the risk for violence, HIV, injuries, and other 
negative outcomes (CDC, 2010). Moreover, excessive alcohol use is a leading cause of 
preventable death and is associated with over $200 billion in economic costs (Bouchery, 
Harwood, Sacks, Simon, & Brewer, 2011; Mokdad, Marks, Stroup, & Gerberding, 2004). 
It is therefore a priority to understand the determinants of alcohol use in youth in order to 
elucidate factors salient to prevention. There is some evidence that serotonin functioning 
is a risk factor for alcohol use, such that lower levels of serotonin functioning tend to 
predict greater levels of alcohol use. This evidence has been provided by experimental 
studies that manipulate serotonin, studies that measure serotonin levels through drug 
challenge, metabolite levels, or receptor binding, and studies of measured serotonergic 
genes (see LeMarquand, Pihl, & Benkelfat, 1994a, for a review).  
However, the mechanisms through which serotonin functioning increases the risk 
for alcohol use are less clear. Although many diverse mechanisms have been proposed 
(e.g., Canli & Lesch, 2007; Carver, Johnson & Joorman, 2008; Hariri & Holmes, 2006; 
Heinz, Mann, Weinberger, & Goldman, 2001; Lesch, 2005), an integrated model that 
coherently outlines the pathways from serotonin functioning to alcohol use has not yet 
been established. Additionally, few longitudinal studies have been utilized to 
prospectively examine these possible mechanisms. Investigating the mechanisms 
underlying serotonin functioning and alcohol use in a longitudinal framework would 
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inform the etiology of alcohol use and disorder and guide prevention and intervention 
efforts. 
The Serotonergic System and Methods for Measuring Serotonin Functioning 
The serotonergic system is one of the most widely distributed neurotransmitter 
systems in the brain, with the majority of serotonin neurons located along the midline of 
the brainstem. Long axons from these neurons project out to many areas of the nervous 
system (van Goozen, Fairchild, Snoek, & Harold, 2007). Although not fully understood, 
many factors can influence the overall functioning of the serotonergic system. These 
include the levels of available serotonin, serotonin receptor density and sensitivity, the 
efficiency of serotonin reuptake and metabolism, the recency of cell firing, and the 
consumption of amino acids (Carver, Johnson, & Joorman, 2008; Neumeister et al., 
2006). Genetic variation also influences serotonin functioning, possibly through several 
of these processes.  
Various methods have been used to measure serotonin functioning in the 
literature. Although it would be optimal to measure levels of serotonin in the brain 
directly, this is often not possible with human subjects because of its invasive nature. One 
common method that is less invasive is to measure the amount of 5-hydroxyindoleacetic 
acid (5-HIAA), which is a major metabolite of serotonin, present in the cerebrospinal 
fluid (CSF). Lower levels of CSF 5-HIAA might indicate decreased serotonin 
metabolism in the central nervous system and, therefore, have been interpreted to reflect 
lower levels of serotonin in the brain. Interestingly, studies have shown that levels of 5-
HIAA in the CSF are correlated with levels of 5-HIAA in the brains of post-mortem 
human subjects and non-human primates (Huggins et al., 2012; Stanley et al., 1985). This 
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suggests that CSF 5-HIAA may be a good proxy for serotonergic system processes in the 
brain. Researchers have also used the drug challenge method. In this method, a drug that 
is a precursor, agonist, or releaser of serotonin is administered and subsequent changes in 
hormones that are sensitive to changes in serotonin are assessed (such as prolactin or 
cortisol). Blunted hormonal responses to drug challenges are interpreted to indicate lower 
levels of serotonin functioning. Another common method is called acute tryptophan 
depletion or enhancement. It involves temporarily lowering or heightening levels of 
serotonin by depleting or enhancing, respectively, levels of the serotonin precursor, 
tryptophan.  
Finally, researchers have studied serotonin functioning by examining the role of 
genetic polymorphisms thought to play a role in the serotonin system. For example, one 
of the most widely studied serotonin polymorphisms is the functional insertion-deletion 
polymorphism in the 5-HTT linked promotor region (5-HTTLPR). This polymorphism is 
tri-allelic, although only two alleles have been commonly studied (i.e., the short and long 
alleles). Many other genetic polymorphisms thought to influence serotonin functioning 
have also been studied, although an extensive review of these polymorphisms is beyond 
the scope of this manuscript (see Dick & Foroud, 2003 for a review; see McHugh, 
Hofmann, Asnaani, Sawyer, & Otto, 2010 for a meta-analysis and review).  
The current study will utilize genomic data in order to measure serotonin 
functioning. It is now widely recognized that serotonin functioning is polygenic in nature 
(i.e., involving many genes of small effect size). Also, genetic polymorphisms located 
within serotonin genes are not solely responsible for overall serotonin functioning, but 
the current literature has mainly used single serotonin variants to index this construct. 
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Therefore, the current study will improve upon these previous studies by creating a 
polygenic risk score to index serotonin functioning. Specifically, a polygenic risk score 
consisting of the additive effect of multiple single nucleotide polymorphisms (SNPs) will 
be created using results from an independent genome-wide association study (GWAS; 
Luykx et al., 2014). This GWAS examined the relations among thousands of common 
variants and CSF 5-HIAA concentrations in a sample of European adults. Thus, the 
polygenic score will index genetic risk for levels of CSF 5-HIAA functioning, which has 
been posited to index levels of serotonin functioning in the brain. For simplicity, this 
genetic risk score will be referred to as polygenic risk for serotonin functioning 
throughout the text, such that greater levels of polygenic risk reflect lower levels of 
serotonin functioning.  
Unlike most other studies that have created polygenic risk scores indexing 
specific psychological disorders, this polygenic risk score attempts to explain variation in 
an endophenotype of a disorder (i.e., serotonin functioning). Endophenotypes have been 
defined as neurobiological, cognitive, or psychological constructs that are heritable and 
might be intermediate in the relation between genes and more distal outcomes, such as 
alcohol use and disorder (Gottesman & Gould, 2003). Gottesman and Gould (2003) 
highlighted the importance of examining endophenotypes to better understand the genetic 
architecture of psychological problems. Indeed, psychological disorders as they are 
defined in current classification systems do not map onto specific genes in a one-to-one 
fashion. This is likely because psychological disorders have been defined by observable 
symptom clusters that are heterogeneous, share many commonalities with other disorders, 
and simply do not “carve nature at its joints” (Mendelsohn et al., 1982, pp. 1168-1169). 
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Given this information, is seems important to examine polygenic risk for an 
endophenotype of alcohol use (i.e., serotonin functioning) to help elucidate the genetic 
underpinnings of alcohol use and disorder. In addition, most polygenic risk scores created 
to date do not directly inform how genes functionally influence these psychological 
problems. The current study will fill these gaps in the literature by creating a polygenic 
risk score for an endophenotype of alcohol use, serotonin functioning. This score will 
have direct implications for understanding the functional influence of genes on 
psychological problems.  Moreover, using this methodology might shed light on the 
mechanisms in the relation between serotonin functioning and greater alcohol use.  
Serotonin Functioning and Alcohol Use 
An extensive literature of both animal and human studies suggests that serotonin 
functioning in the brain is linked with alcohol consumption and dependence (see 
LeMarquand et al., 1994a, 1994b for a review). For instance, the depletion of brain 
serotonin levels in rodents increases their alcohol consumption, and the restoration of 
serotonin levels reverses this effect (Naranjo, Sellers, & Lawrin, 1986). Interestingly, 
rodent strains bred with an alcohol preference tend to have lower serotonin levels than 
rodents without an alcohol-preference, even prior to alcohol exposure (Gongwer et al., 
1989; Murphy et al., 1982). This suggests that animals with lower levels of brain 
serotonin are at premorbid risk for alcohol consumption.  
In addition, human studies show that CSF 5-HIAA concentrations are lower in 
alcoholics compared to controls after a period of abstinence (Ballenger et al., 1979; 
Banki, 1981; Borg et al., 1985) and lower in individuals with early onset alcoholism 
(prior to the 25 years of age) compared to individuals with late-onset alcoholism (Füs-
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Aime et al., 1996). In the latter study, CSF 5-HIAA levels also did not differ between 
alcoholics who did or did not have depression, antisocial behavior, or history of suicide 
attempts (Füs-Aime et al., 1996). This suggests that the relation between serotonin 
function and alcoholism may not be conditional upon the presence or absence of these co-
occurring conditions. Drug challenge studies also found similar results. These studies 
have shown that male alcoholics with no other Axis I diagnoses and 2 weeks of 
abstinence, adult alcoholics with 2 weeks of abstinence, and non-abstinent heavy drinkers 
had blunted hormonal responses to serotonin agonists or releasers (Balldin et al., 1994; 
Farren et al., 1995; Lee & Meltzer, 1991). Ernouf et al., (1993) also found that abstinent 
adult alcoholics had increased serotonin uptake compared to controls, indicating less 
serotonin in the synaptic cleft available for neurotransmission.  
In addition to showing that serotonin functioning and alcoholism have a cross-
sectional or correlational relation, human studies have shown that serotonin functioning 
might be a heritable, premorbid risk factor for alcohol consumption and dependence. 
Indeed, studies showed that individuals with a family history of alcoholism had lower 
levels of serotonin functioning than individuals without, even prior to chronic exposure to 
alcohol. For instance, both children of alcoholics who had never had alcohol and non-
abstaining adult male offspring of alcoholics who did not have any DSM-III Axis I 
disorders had higher platelet serotonin uptake compared to control participants (Ernouf et 
al., 1993; Rausch et al., 1991). Interestingly, one study found that abstinent alcoholics 
who had both an alcoholic mother and father had lower CSF 5-HIAA concentrations 
compared to alcoholics who had only one alcoholic parent (Füs-Aime et al., 1996). This 
suggests that serotonin functioning could be a heritable risk factor because alcoholics 
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with denser family histories of alcoholism are likely to have greater genetic 
vulnerabilities for alcoholism compared to alcoholics with less dense family histories. 
Genetic studies also point to the possibility that serotonin functioning is a 
premorbid, heritable risk factor. Indeed, genotypic variation should rarely be influenced 
by an individual’s alcohol consumption (although the expression of genotypic variation 
might be influenced). Along these lines, in a meta-analysis on the 5-HTTLPR 
polymorphism, Feinn, Nellissery & Kranzler (2005) found that the frequency of the short 
allele was significantly associated with alcohol dependence. The short allele has been 
associated with lower levels of serotonin uptake. This functional difference results in 
greater amounts of serotonin in the synapse for neurotransmission (Lesch et al., 1996). 
This finding may seem counterintuitive to the notion that individuals with lower levels of 
serotonin functioning have greater rates of alcoholism. However, an extensive review 
posited that excess levels of serotonin present during early central nervous system 
development might inhibit the ultimate outgrowth, size, and capacity of the serotonin 
system through negative feedback processes (Nordquist & Oreland, 2010). Note that we 
did not include the 5-HTTLPR polymorphism in the current polygenic risk score because 
we had no information about how it relates with 5-HIAA in the CSF. Numerous studies 
including one meta-analysis also found links between other serotonin SNPs and alcohol 
phenotypes (e.g., Cao, LaRocque & Li, 2013; Enoch, Gorodetsky, Hodgkinson, Roy, & 
Goldman, 2011; Polina, Contini, Hutz, & Bau, 2009; Zlojutro et al., 2011). Collectively, 
these studies suggest that serotonin functioning might represent a heritable biological risk 
factor for alcohol consumption and dependence, such that lower levels of serotonin 
functioning predict greater alcohol use.   
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Despite the volume of research on the link between serotonin functioning and 
alcohol phenotypes, the mechanism(s) underlying this relation are less clear. Among 
others, researchers have posited that social cognition (Canli & Lesch, 2007), negative 
emotionality (Heinz, Mann, Weinberger, & Goldman, 2001), impulsivity (Soubriè, 1986), 
low behavioral inhibition (Depue & Spoont, 1986; Gray, 1982), a low level of response 
to the acute effects of alcohol (Heinz et al., 2001), and emotion and self-regulation 
(Carver, Johnson & Joorman, 2008; Hariri & Holmes, 2006; Lesch, 2005) might be 
mechanisms that mediate the relation between serotonin functioning and alcohol use and 
dependence. Unfortunately, few studies have utilized longitudinal models to directly test 
the mechanisms through which serotonin functioning influences the risk for alcohol use 
over development. Indeed, if serotonin functioning is a premorbid risk factor for alcohol 
problems, there are likely earlier-appearing behaviors or traits in youth (i.e., occurring 
prior to alcohol initiation) that would help explain this relation. Testing an integrated, 
longitudinal model that coherently outlines the pathways from serotonin functioning and 
alcohol use is needed to better understand the etiology of alcohol use and disorders. 
The Role of Serotonin Functioning in Aggressive/Antisocial and Depressive 
Symptoms 
Some of the most consistently replicated associations in the literature on serotonin 
function are those between serotonin function and impulsive aggression and serotonin 
function and depression (see Carver et al., 2008). The pattern of these relations is such 
that lower levels of serotonin are associated with greater levels of depression and 
impulsive aggression. This body of work might be useful in further understanding the 
relation between serotonin functioning and alcohol use for several reasons. First, 
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aggressive/antisocial and depressive symptoms generally appear at younger ages than 
does alcohol use and both types of problem behavior increase the risk for later alcohol 
use and disorder. Thus, youth with lower levels of serotonin functioning might be at risk 
for aggressive/antisocial behaviors and depressive symptoms. These same youth may 
begin to use alcohol because they affiliate with deviant peers and/or to self-medicate (see 
Sher, 1991). Furthermore, it is possible that aggressive/antisocial behaviors, depressive 
symptoms, and alcohol use could actually represent age-specific expressions of serotonin 
functioning (i.e., heterotypic continuity). Thus, it may be critical to pay close attention to 
the vast literatures on serotonin functioning, aggressive/antisocial behaviors and 
depressive symptoms to better understand the etiology and development of alcohol use 
and disorder.   
Multiple lines of evidence indicate that serotonin functioning may be associated 
with aggressive/antisocial behavior, such that lower levels of serotonin functioning are 
associated with greater levels of aggression/antisocial behavior. Studies have shown that 
adults and children who displayed aggressive and violent behavior and children who had 
disruptive behavior disorders and/or attention deficit/hyperactivity disorder (ADHD) had 
lower levels of CSF 5-HIAA compared to control groups (Brown et al., 1982; Brown, 
Goodwin, Ballenger, Goyer, & Major, 1979; Kruesi et al., 1990, 1992; Lidberg, Tuck, 
Asberg, Scalia-Tomba, & Bertilsson, 1985; Limson et al., 1991; Roy, Adinoff, & 
Linnoila, 1988; Virkkunen, Nuutila, Goodwin, & Linnoila, 1987). A series of studies also 
found that CSF 5-HIAA concentrations were lower in infants with a family history of 
antisocial personality compared to infants without a family history, and predicted infants’ 
      
 10  
externalizing behaviors at 30 months of age (Clarke, Murphy, & Constantino, 1999; 
Constantino, Morris, & Murphy, 1997).  
In addition, conduct-disordered children with less dense serotonin receptors had 
greater aggressive behaviors (Birmaher et al., 1990; Stoff, Pollock, Vitiello, Behar, & 
Bridger, 1987). Compared to controls, serotonin receptor density was also found to be 
lower in delinquent adolescents and lower in boys whose parents had a history of 
substance abuse or incarceration (Blumensohn et al., 1995; Pine et al., 1996). Twitchell et 
al. (1998) found that lower whole blood serotonin levels were associated with higher 
behavioral problems in children of alcoholics. Furthermore, blunted hormonal responses 
to drug challenge were associated with greater aggressive behaviors in a group of boys 
with ADHD, prospectively predicted antisocial personality disorder in boys with ADHD 
9 years later, and prospectively predicted greater aggression and antisocial behavior in 
adolescent males 7 years later (Flory, Newcorn, Miller, Harty & Halperin, 2007; Halperin 
et al.,2006).  
A number of genetic variants associated with reduced serotonin, such as the short 
allele of the 5-HTTLPR polymorphism and the low activity form of the MAO-A gene, 
have also been implicated in antisocial/violent behavior and intermittent explosive 
aggression (Brunner, Nelen, van Zandvoort, et al., 1993; Brunner, Nelen, Breakefield, 
Ropers, & van Oost, 1993; Liao, Hong, Shih, & Tsai, 2004; Lyons-Ruth et al., 2007). It is 
important to note that studies of adults, as opposed to studies of children, have been more 
consistent in demonstrating associations between serotonin functioning and 
aggressive/antisocial behaviors (see van Goozen et al., 2007 for a comprehensive 
review). Although the data are less consistent for children, researchers have posited that 
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these inconsistencies might be due to differences in the composition of antisocial samples 
across studies such as using only ADHD children with comorbid aggression and 
antisociality vs. a more homogeneous aggressive group (van Goozen et al., 2007). 
Research also suggests that serotonin functioning contributes to depressive 
symptoms, such that lower levels of serotonin functioning are associated with greater 
depressive symptoms. Studies demonstrated that CSF 5-HIAA levels were reduced in 
depressed patients compared to healthy controls, reduced in depressed patients who had 
more frequent hospitalizations, and increased after recovery from depression (Asberg et 
al., 1976; Dencker, Malm, Roos, & Werdinius, 2006; Traskman-Bendz et al., 1984; van 
Praag & de Haan, 1979). Blunted hormonal response to drug challenge was also found 
among depressed adults and children and among children with a high familial loading of 
major depressive disorder (Birmaher et al., 1997; Flory et al., 1998; Lichtenberg et al., 
1992; Siever, Murphy, Slater, de la Vega, & Lipper, 1984). Studies also showed that 
depressed patients had lower plasma tryptophan levels and decreased platelet serotonin 
uptake compared to controls (Coppen et al., 1973; Cowen et al., 1989; Healy & Leonard, 
1987). 
Moreover, acute tryptophan depletion has been shown to temporarily induce 
several different symptoms of depression. Among these include temporary increases in 
depressive symptoms in individuals with histories of major depressive disorder, cognitive 
deficits, memory impairments, and, in those with a family history of major depressive 
disorder, increased negative affect and vegetative symptoms (Benkelfat et al., 1994; 
Booij & Van der Does, 2007; Booij et al., 2002; Delgado, Charney, Price, & Aghajanian, 
1990; Delgado et al., 1999; Klaassen et al., 1999; Lam et al., 1996; Moreno et al., 1999; 
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Munafò, Hayward, & Harmer, 2006; Neumeister et al., 2002, 2006; 2004; Porter et al., 
2005; Sambeth et al., 2007; Smith, Clifford, Hockney, Clark, & Cowen, 1997). A number 
of studies have also found that the 5-HTTLPR polymorphism is implicated in depression 
(see Clarke, Flint, Attwood & Munafo, 2010 for a review and meta-analysis). In addition, 
the 5-HTTLPR polymorphism has been shown to have a main effect on, and to interact 
with adverse life events to predict, depressive symptoms in children and adolescents 
(Eley et al., 2004; Kaufman et al., 2004, 2006). Finally, studies have shown that other 
serotonin gene variants are associated with depression phenotypes as well (see Levinson, 
2006).  
However, the fact that aggressive/antisocial and depressive symptoms co-occur at 
a higher rate than would be expected by chance in both community and clinical samples 
could confound the associations mentioned previously (Angold & Costello, 1993; 
Zoccolillo, 1992). The relation between serotonin functioning and aggressive/antisocial 
symptoms could be confounded by its co-occurrence with depression if serotonin 
functioning has a true influence on only depression, and vice versa. However, at least 
some studies indicate that this is not the case. For example, studies show that serotonin 
mediated hormonal responses were blunted in those with only major depressive disorder 
and no other DSM-III diagnoses (Cleare, Murray, & O’Keane, 1996, 1998). Also, 
depressed patients with no other major psychiatric or personality disorders had a reduced 
sensitivity of 5-HT1D receptor binding when compared with controls (Cleare, Murray, 
Sherwood, & O’Keane, 1998). Birhmaher et al. (1990) found that the density of serotonin 
binding was associated with lower externalizing problems in a sample of children with a 
history of aggression and/or impulsivity but who did not have DSM-III affective 
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disorders. Moreover, in a review, Coccaro (1992) established that greater levels of 
aggressive/antisocial behaviors in adults were associated with lower levels of serotonin 
functioning, independent of co-occurring depression.  
Along similar lines, alcohol use and disorder, aggressive/antisocial behaviors and 
depression also co-occur at a high rate (Kendler, Heath, Neale, Kessler, & Eaves, 1993; 
Krueger et al., 2002). Thus, serotonin function might have a true influence on alcohol 
consumption only, and might be spuriously associated with aggressive/antisocial 
behaviors or depression due to co-occurrence. However, the available evidence does not 
support this hypothesis either. For example, in one meta-analysis, adults with antisocial 
behavior had lower levels of CSF 5-HIAA compared to adults without antisocial 
behavior. This effect was not moderated by alcoholism, suggesting that this relation was 
not solely due to co-occurrence with alcoholism. Also, indices of serotonin functioning 
predicted aggressive/antisocial behaviors in children even prior to the development of 
alcohol problems or alcohol initiation (e.g., Birmaher et al., 1990; Clarke, Murphy, & 
Constantino, 1999; Constantino, Morris, & Murphy, 1997; Pine et al., 1996; Stoff, 
Pollock, Vitiello, Behar, & Bridger, 1987; Twitchell et al., 1997). Studies have also 
shown that depressed individuals with no history of substance dependence or past year 
substance abuse had lower 5- HT functioning as measured by receptor binding potential, 
decreased uptake, and blunted prolactin response when compared with controls (Cannon 
et al., 2007; Drevets et al., 1999; Mann et al., 1995; Tuomisto, Tukianen, & Ahlfors, 
1979). In summary, it appears that serotonin functioning is a common biological 
diathesis, such that lower levels of serotonin functioning may increase the risk for greater 
levels of aggressive/antisocial and depressive symptoms. These effects also appear to be 
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independent of alcoholism, co-occurring depressive symptoms and/or co-occurring 
aggressive/antisocial behaviors. 
Mechanisms to Explain a Common Biological Diathesis in the Divergent Outcomes 
of Aggressive/Antisocial and Depressive Symptoms 
The fact that serotonin functioning predicts both aggressive/antisocial and 
depressive symptoms might be surprising given that these two types of problem behavior 
lie on distinct spectra of psychopathology (i.e., internalizing vs. externalizing; Achenbach 
& Edelbrock, 1978). However, one relatively recent theory might help reconcile this 
apparent discrepancy. Carver et al. (2008) posited that individuals with lower levels of 
serotonin functioning are predisposed towards lower levels of top-down, reflective self-
regulation, which in turn increases the relative dominance of bottom-up, reflexive 
control. As the name suggests, reflective regulation describes an individual’s ability to 
voluntarily and flexibly regulate and plan behaviors, emotions, and thoughts. On the 
other hand, reflexive control describes an individual’s automatic and relatively 
involuntary predisposition towards approach or avoidance. Individuals may regulate their 
reflexive control tendencies by voluntarily mobilizing reflective self-regulatory abilities. 
For example, an individual predisposed towards approaching rewarding stimuli due to a 
relatively reflexive approach tendency might nonetheless have the ability to regulate this 
desire by mobilizing top-down self-regulatory skills. Conversely, an individual 
predisposed towards avoiding novel situations in spite of the potential rewards might 
have the ability to regulate this tendency by mobilizing self-regulation. 
Parallel constructs have been described in the literature on temperament. Effortful 
control is the regulatory component of temperament defined as, “the efficiency of 
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executive attention-including the ability to inhibit a dominant response and/or to activate 
a subdominant response, to plan, and to detect errors” (Rothbart & Bates, 2006, p. 129). 
Effortful control is a voluntary form of regulation that allows individuals to respond 
adaptively to the situation at hand (Eisenberg, Spinrad, & Morris, 2002) and is an 
analogue of the top-down regulation described by Carver et al. (2008). Unlike effortful 
control, reactive control is an aspect of temperament that describes relatively involuntary 
and automatic control (Eisenberg & Morris, 2002). Reactive control describes an 
individual’s tendency to approach rewards or to avoid and withdraw, especially in novel 
situations, and is an analogue of the bottom-up control described by Carver et al. (2008).  
Carver et al. (2008) posited that individuals with lower levels of serotonin 
functioning experience breakdowns in reflective self-regulation/effortful control, which 
then results in the expression of pre-existing vulnerabilities to either approach or 
avoidance (i.e., one’s bottom-up, or reactive, control tendencies). Therefore, they 
hypothesized that deficits in serotonin and subsequent declines in voluntary regulation 
would predict depression, but only if the individual was also predisposed to reflexive 
inhibition, withdrawal, or avoidance. Conversely, deficits in serotonin and subsequent 
declines in voluntary regulation would predict aggressive/antisocial behaviors, but only if 
the individual was also predisposed to reflexive approach and reward sensitivity. In sum, 
this model suggests that serotonin functioning predicts the divergent outcomes of 
depression and aggressive/antisocial behaviors due its role in producing a common 
vulnerability to low effortful control/voluntary self-regulation. Although 
reflexive/reactive control is an important aspect of this theory, the goal of the current 
study is to elucidate the common vulnerability produced by serotonin functioning. 
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Therefore, the subsequent review of the literature will focus on the role of serotonin 
functioning in the development of reflective self-regulation/effortful control.  
The Role of Serotonin Functioning in Reduced Self-Regulation/Effortful Control 
In support of Carver et al. (2008)’s theory, studies suggest that individuals with 
lower levels of serotonin functioning might have lower levels of effortful control and 
related self-regulatory capacities (also see Hariri & Holmes, 2006; Lesch, 2005; Lucki, 
1998). Corticolimbic circuits that are responsible for mediating emotional behaviors are 
densely innervated by serotonin neurons (Hariri & Holmes, 2006). The underlying 
neurobiology of the higher-order regulatory temperament system likely involves the 
dorsal and lateral prefrontal cortex and anterior cingulate cortex (Carver, Johnson, & 
Joorman, 2008; White, Lamm, Helfinstein, & Fox, 2012). Studies showed that the 
experimental depletion of serotonin levels via tryptophan depletion attenuated activity in 
the dorsolateral/medial prefrontal cortex during a working memory task and in the 
anterior cingulate cortex (Allen et al., 2006; Smith, Morris, Friston, Cowen, & Dolan, 
1999). Such effects appeared to be especially prominent among individuals with the short 
allele of the 5-HTTLPR polymorphism, which is implicated in serotonin functioning 
(Neumeister et al., 2006). Another study found that carriers of the short allele of the 5-
HTTLPR polymorphism had smaller gray matter volume in a region of the prefrontal 
cortex (Pezawas et al., 2005). Furthermore, serotonin genes appear to influence the 
executive attention network, which is involved in regulating brain networks implicated in 
thought and emotion and is empirically related to effortful control in childhood (Canli et 
al., 2005; Gerardi-Caulton, 2000; Posner, Sheese, Odludas, & Tang, 2006; Reuter, Ott, 
Vaitl, & Hennig, 2007; Rothbart, Ellis, Rueda, & Posner, 2003). Thus, individuals with 
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lower levels of serotonin functioning may have attenuated activity of brain regions 
involved in higher-order self-regulation.  
Serotonin functioning has also been associated with individuals’ ability to inhibit 
their emotional and behavioral responses, which might reflect self-regulatory abilities. 
For instance, the reduction of serotonin availability via tryptophan depletion made it 
more difficult for individuals to inhibit responses to cues that were formerly rewarded, 
especially among individuals with high baseline levels of impulsivity, and increased 
aggression only in those with pre-existing aggressive tendencies (Cleare & Bond, 1995; 
Cools, Blackwell, et al., 2005; Finn, Young, Pihl, & Ervin, 1998). Tryptophan depletion 
also caused greater responsivity to negative emotional cues in formerly depressed 
individuals but not in individuals with no history of depression (Hayward, Goodwin, 
Cowen, & Harmer, 2005). Similarly, tryptophan depletion elevated the risk for negative 
affect and vegetative depressive symptoms in individuals with a family history of major 
depression but not for individuals with no such family history (Benkelfat et al., 1994; 
Klaassen et al., 1999; Neumeister et al., 2002). Thus, experimental studies produce 
divergent effects, such as increases in depressive symptoms or aggression, but only or 
more strongly for those who are predisposed to such traits. This pattern of results 
suggests that the depletion of serotonin influences one’s ability to regulate underlying 
reflexive or reactive emotions and behaviors.  
Regarding the role of serotonin genetic polymorphisms, Kochanska, Philibert, and 
Barry (2009) found that children who carried the short allele of the 5-HTTLPR 
polymorphism and were also insecurely attached developed poorer effortful control when 
compared with children who were securely attached. Similarly, Nederhof et al. (2010) 
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found that childhood stressful events predicted lower effortful control only in children 
with the short allele of the 5-HTTLPR polymorphism and the Met allele of the BDNF 
Val66Met polymorphism. Collectively, these studies suggest that serotonin functioning 
might be related to impairments in the regulation of emotion and behavior on both a 
neurological and behavioral level. Note that if this is true, serotonin functioning should 
also relate to ADHD symptoms through lowered effortful control, given that ADHD is a 
disorder characterized by executive inhibition deficits (Nigg, 2001). However, this is 
beyond the scope of the current study, which aims to understand pathways to alcohol use, 
and ADHD is not as robust a predictor of alcohol use and disorder after considering 
aggressive/antisocial behaviors (Disney, Elkins, McGue, & Iacono, 1999).  
The Role of Effortful Control in Aggressive/Antisocial and Depressive Symptoms 
Studies also show that poor effortful control is a common mechanism that 
predisposes to both aggressive/antisocial and depressive symptoms, providing further 
support for Carver et al (2008)’s theory. For example, studies showed that poorer 
effortful control predicted adolescents’ greater conduct problems both cross-sectionally 
and prospectively (Loukas & Roalson, 2006; Loukas & Robinson, 2004; Wang, Chassin, 
Eisenberg, & Spinrad, 2015a). Furthermore, deficits in effortful control have been related 
to peer reports of children’s involvement in anger and conflict situations (Murphy & 
Eisenberg, 1997), higher levels of proactive and reactive aggression (de Castro, Merk, 
Koops, Veerman, & Bosch, 2005; Xu, Farver, & Zhang, 2009), broad measures of 
aggression (Dennis & Brotman, 2003; Muris, Van Der Pennen, Sigmond, & Mayer, 
2008), and more rapid expressions of anger (Kochanska, Murray, & Harlan, 2000).  
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Similarly, cross-sectional studies have found that effortful control is related to 
depressive symptoms, such that lower levels of effortful control are associated with 
greater depressive symptoms (Loukas & Robinson, 2004; Muris, van der Pennen, 
Sigmond, & Mayer, 2008; Verstraeten, Vasey, Raes, & Bijttebier, 2009). Wang et al., 
(2015a) found that individuals with lower levels of effortful control had greater 
depressive symptoms over time, but other studies either found marginally significant or 
no significant effects of effortful control on depressive symptoms (Loukas & Roalson, 
2006; Verstraeten, Vasey, Raes, & Bijttebier, 2009). Moriya and Tanno (2008) found that 
depressive symptoms were related to inhibitory, but not attentional, control after 
accounting for comorbidity with other internalizing problems. On the other hand, in a 
review of the literature Compas, Connor-Smith, and Jaser (2004) concluded that 
attentional control was likely implicated in child and adolescent depression. Interestingly, 
a recent meta-analysis by Snyder (2013) showed in a synthesis of 113 studies that adult 
major depressive disorder was associated with deficits on a host of neuropsychological 
measures of executive functioning likely involved in effortful control. Thus, it appears 
that self-regulatory capacities might be important in the development of depressive 
symptoms.  
In summary, multiple lines of evidence suggest that serotonin functioning might 
predict the divergent outcomes of aggressive/antisocial behaviors and depression because 
it creates a common vulnerability to poor effortful control. 
Relevance to the Etiology of Alcohol Use 
As stated earlier, researchers have proposed a multitude of mechanisms that might 
be involved in the relation between serotonin functioning and alcohol use and disorder. 
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However, increasing the specificity and clarity of these mechanisms is obviously needed 
to better understand the link between serotonin functioning and adolescents’ alcohol use. 
Because research suggests that serotonin functioning is a premorbid risk factor for 
alcohol use and disorder, it would be surprising if this pre-existing biological 
vulnerability did not influence other types of psychological problems prior to the onset of 
alcohol problems. Alternatively, this pre-existing biological vulnerability could simply 
influence the development of certain types of adolescent symptomatology that, in turn, 
increase the risk for alcohol use. Therefore, it would be useful to understand the 
mechanisms in the relation between serotonin function and alcohol problems that appear 
earlier in youth. 
Indeed, aggressive/antisocial and depressive symptoms are phenomena that 
increase sharply in prevalence during adolescence, and effortful control is evident even 
earlier (Loeber & Keenan, 1994; Murphy, Eisenberg, Fabes, Shepherd, & Guthrie, 1999). 
In addition, these constructs have been shown to predict later alcohol use outcomes. For 
instance, poorer effortful control has been associated with a variety of substance use 
outcomes (Cheetham, Allen, Yücel, & Lubman, 2010; Creemers et al., 2010; Willem et 
al., 2011). In addition, adolescents’ aggressive/antisocial and depressive symptoms are 
robust predictors of later substance outcomes over and above other types of 
psychopathology. (e.g, Hussong & Chassin 1994; Fleming, Mason, Mazza, Abbot, & 
Catalano, 2008; Pardini, White & Stouthamer-Loeber, 2007). Finally, it is evident from 
the previous review that effortful control, aggressive/antisocial, and depressive symptoms 
might share a common biological vulnerability with alcohol problems (i.e., serotonin 
functioning).  
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Thus, an integrated, longitudinal model of the development of alcohol use in 
adolescence might involve the following. First, individuals with a pre-existing heritable 
vulnerability for lower levels of serotonin function might have lower levels of effortful 
control. This common vulnerability to poorer effortful control might then lead to the 
divergent outcomes of aggressive/antisocial or depressive symptoms in adolescence, a 
time when these behaviors become more prominent. Adolescents with 
aggressive/antisocial symptoms might subsequently use alcohol because they affiliate 
with deviant peers (Sher, 1991), or due to shared personality traits (e.g., sensation 
seeking). Alternatively, aggressive/antisocial behaviors and alcohol use might both 
simply be age-specific manifestations of serotonin functioning and effortful control. 
Similarly, individuals with depressive symptoms might use alcohol to alleviate negative 
emotions or because they affiliate with rejected/deviant peers (Sher, 1991). Alternatively, 
depressive symptoms and alcohol use might both simply be age-specific manifestations 
of serotonin function and/or effortful control. Finally, any direct effects observed from 
serotonin functioning to alcohol use may indicate that other untested mechanisms are at 
play in this relation. The current study will test this integrated, longitudinal model of 
adolescents’ alcohol use using a polygenic risk score indexing CSF 5-HIAA 
concentrations as a marker of a heritable predisposition for serotonin functioning (See 
Figure 1).  
Potential Moderating Role of Gender 
 There are gender differences in effortful control, aggressive/antisocial symptoms, 
depressive symptoms, and alcohol problems. Numerous studies indicate that males 
generally have lower levels of effortful control and depressive symptoms and higher 
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levels of aggressive/antisocial symptoms and alcohol use and disorders than do females 
(Bongers, Koot, van der Ende, & Verhulst, 2003; Else-Quest et al., 2006; Lemery, Essex, 
& Smider, 2002; Nolen-Hoeksema & Girgus, 1994). These gender differences might lead 
some of the paths in the proposed models to be stronger for males or females to the extent 
that males or females have greater variability in these constructs. For example, it is 
possible that the links among effortful control, aggressive/antisocial symptoms and 
alcohol use would be stronger in males than in females. However, previous studies 
investigating these relations provide mixed evidence. For instance, research suggested 
that effortful control predicted externalizing problems similarly for boys and girls, such 
that lower levels of effortful control predicted greater levels of externalizing problems 
(Eisenberg et al., 2005, 2009). This suggests that lowered self-regulatory abilities 
influence the development of externalizing problems equally for boys and girls. Also, 
several studies suggest that behavioral undercontrol, externalizing behaviors, and 
antisociality predicted alcohol phenotypes equally in males and females (Moffitt, Caspi, 
Rutter, & Silva, 2001; Slutske et al., 2002). On the other hand, other studies found that 
antisociality and behavioral undercontrol predicted alcohol phenotypes more strongly for 
males than for females (Caspi, Moffit, Newman, & Silva, 1996; Hussong, Curran, & 
Chassin, 1998). Thus, although there is little evidence that effortful control would more 
strongly, or only, predict aggressive/antisocial behaviors in males when compared to 
females, it is possible that aggressive/antisocial behaviors would more strongly, or only, 
predict alcohol problems in males when compared to females.  
  Females are almost twice as likely to be diagnosed with depression when 
compared with males (Nolen-Hoeksema & Girgus, 1994). In addition, researchers have 
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found gender differences in the links between depression and alcohol phenotypes. When 
measured longitudinally (over the span of a year or more), researchers have generally 
found that the link between depression and alcohol use and disorder was stronger for 
women than for men in community samples, high-risk samples, and among alcoholics 
(Chassin et al., 2002; Fillmore et al., 1997; Helzer & Pryzbeck, 1988; Olenick & 
Chalmers, 1991; Rubonis et al., 1994). However, despite the higher prevalence of 
depression in females, there is little evidence to suggest that effortful control predicts 
depressive symptoms more strongly, or only, for females when compared with males 
(Eisenberg et al., 2005; 2009). Thus, lowered self-regulatory abilities might contribute 
equally to the development of depressive symptoms in males and females, whereas 
depressive symptoms might predict alcohol use more strongly, or only, for females when 
compared with males.  
 Finally, few studies have specifically investigated gender differences in the 
relation of serotonin functioning to effortful control, aggressive/antisocial symptoms, 
depressive symptoms, or alcohol use. However, some studies have shown that early 
onset/Cloninger’s Type II alcoholics might have lower levels of serotonin functioning 
when compared with late onset/Type I alcoholics (Virkkunen & Linnoila, 1990). Early 
onset/Type II alcoholics have been classified as a primarily male group that is 
particularly prone to antisocial and violent behaviors and that often has a family history 
of alcoholism. Late onset/Type I alcoholics have been classified as a group that uses 
alcohol primarily to relieve anxiety and that has high harm avoidance and low novelty 
seeking. Because alcohol use will be measured in late adolescence through emerging 
adulthood in the current study, it is possible that serotonin functioning might be more 
      
 24  
strongly related to alcohol use for males than for females to the extent that the alcohol use 
measure captures the early onset/Type II group. Because of the possibility that proposed 
paths will differ by gender, all paths were tested for moderation by gender.    
Implications and Importance of the Proposed Model 
The pattern of relations elucidated by this model will inform the mechanisms 
underlying alcohol use and disorder. If all hypothesized paths in the model are confirmed, 
this would suggest that serotonin functioning predicts alcohol use through 
aggressive/antisocial and depressive symptoms, and that all of these problem behaviors 
are the result of a common deficit in effortful control (See Figure 1). However, other 
patterns are possible as well. For instance, the polygenic risk score indexing serotonin 
functioning might predict alcohol use only through effortful control and not through 
adolescent psychopathology. This would suggest that serotonin functioning influences 
alcohol use through deficits in self-regulation; however, in this case the link between self-
regulation and alcohol use would likely not be due to the dysregulation of mood, impulse, 
or aggression. Instead, perhaps deficits in self-regulation impede the ability to resist 
alcohol-related cues, to resist alcohol cravings, or to regulate anxiety symptoms, thus 
leading to higher levels of alcohol use. Alternatively, it is possible that the polygenic risk 
score indexing serotonin functioning predicts alcohol use only through depression or 
aggressive/antisocial behaviors and not through effortful control. This would suggest that 
deficient effortful control is not the common vulnerability caused by serotonin 
functioning and that effortful control does not mediate the influence of serotonin 
functioning on the divergent outcomes of depression, aggressive/antisocial behaviors, and 
alcohol use. In addition, if the polygenic risk score indexing serotonin functioning 
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predicts alcohol use directly, this would suggest that mechanisms other than effortful 
control, depression, and aggressive/antisocial behavior mediate this relation. For 
example, researchers have hypothesized a compensatory mechanism whereby individuals 
with lower levels of serotonin functioning misuse alcohol because alcohol consumption 
induces acute increases in brain serotonin levels (LeMarquand et al., 1994a). In addition, 
some research suggests that individuals with lower levels of serotonin functioning are at-
risk for alcohol use and disorder because they have lower levels of response to alcohol 
(Heinz et al., 2001).  
Findings may also inform the developmental pathways to alcohol use and 
disorder. If findings indicate that alcohol use is a common outcome resulting from 
different types of psychopathology, this would provide evidence for equifinality to 
adolescents’ alcohol use. If the polygenic risk score indexing serotonin functioning 
predicts alcohol use through effortful control, aggressive/antisocial behaviors, and 
depression, this would provide evidence of heterotypic continuity. In other words, 
effortful control, aggressive/antisocial behavior, depression, and alcohol might simply be 
different manifestations of deficits in serotonin functioning. Results could also suggest 
another pathway to alcohol use aside from the deviance proneness and stress dampening 
pathways (Sher, 1991). Specifically, an alternate pathway to alcohol use might be a 
common vulnerability towards low effortful control. Note, however, that although this 
model may provide evidence for both heterotypic continuity and for an alternate pathway 
to alcohol use (i.e., effortful control), the model will be unable to distinguish between 
these possibilities.  
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Finally, these results could have implications for the development of a more 
etiologically-based diagnostic system. Existing classification systems are not in 
concordance with current knowledge in biological and psychological research. 
Psychological disorders as they are currently defined do not map onto specific genes or 
neurotransmitter systems in a one-to-one fashion. Instead, genes and neurotransmitter 
systems show relations with a number of putatively distinct mental disorders, suggesting 
that the current diagnostic categories may not very accurately reflect nature. Thus, if 
serotonin functioning predicts depression, aggressive/antisocial behaviors, and alcohol 
use through effortful control, then effortful control would be a useful transdiagnostic 
phenotype that cuts across all of these problem behaviors. This transdiganostic phenotype 
could be used to better classify individuals, tailor research, and guide treatment efforts. In 
summary, results from the current study will inform prevention and intervention efforts, 
elucidate developmental pathways to alcohol problems, and inform more etiologically-
based diagnostic and research classification.  
The Proposed Study 
 The current study used three time points to test whether a polygenic risk score 
indexing serotonin functioning prospectively predicted alcohol use (T3) through effortful 
control (T1) and/or aggressive/antisocial and depressive symptoms (T2). Because some 
of the proposed relations may differ by gender, gender moderation was tested for all of 
the paths in the model. A high-risk longitudinal sample was utilized to test these 
hypotheses, in which approximately half of the participants have a parent with a lifetime 
substance disorder (Adult and Family Development Project; AFDP; Chassin, et al., 
1992). This sample is particularly well-suited to test the proposed model of genetic 
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liability to alcohol use. In addition, the current study replicated these associations in an 
independent longitudinal community sample of adolescents (Child Development Project; 
CDP; Dodge, Bates, & Pettit, 1990).   
It was hypothesized that the polygenic risk score indexing serotonin functioning 
would directly predict effortful control, such that high levels of the polygenic risk score 
(i.e., lower levels of serotonin functioning) would be associated with lower levels of 
effortful control. It was not hypothesized that the polygenic risk score would directly 
predict aggressive/antisocial behaviors and depressive symptoms after accounting for 
effortful control. However, it was expected that polygenic risk would predict these two 
problem behaviors indirectly, through effortful control. Next, it was hypothesized that 
one pathway to greater levels of alcohol use starts with polygenic risk, which predicts 
alcohol use through effortful control and aggressive/antisocial behaviors. A second 
pathway starts with polygenic risk, which predicts alcohol use through effortful control 
and depressive symptoms. It was not expected that effortful control would have a direct 
influence on alcohol use after accounting for the effects of depression and 
aggressive/antisocial behaviors. Finally, a direct path from polygenic risk to greater 
levels of alcohol use was hypothesized. This was based on previous findings showing that 
serotonin functioning had a unique influence on alcohol phenotypes even after 
considering co-occurrence with depression and aggressive/antisocial behaviors.  
Regarding gender moderation, it was expected that the first pathway involving 
polygenic risk, effortful control, aggressive/antisocial behaviors, and alcohol use might 
be stronger, or only present, in males when compared to females. Finally, due to the 
potential moderating role of gender in the relation between depressive symptoms and 
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alcohol use and disorder, it was expected that the second pathway involving polygenic 
risk, serotonin functioning, effortful control, depressive symptoms, and alcohol use might 
be stronger, or only present, in females when compared to males.  
Method 
The Adult and Family Development Project (AFDP) 
 AFDP participants. The first sample of participants for the current study was 
drawn from a larger three-generational longitudinal study of familial alcoholism (Chassin 
et al., 1992). The larger longitudinal study collected data at three annual waves and three 
additional follow-ups which were each separated by five years. Wave 1 commenced in 
1988 and collected data from 454 adolescents (Generation 2s, G2s) and their parents. 246 
of these adolescents had at least one biological custodial parent with alcoholism (COAs) 
and 208 adolescents were demographically matched controls who did not have a parent 
with alcoholism. At wave 4, siblings of G2s were interviewed if they fell within the same 
age range as the original G2s (also referred to as G2s). At wave 5, any remaining non-
interviewed siblings of G2s were recruited to participate in the study, regardless of their 
age, but only if they had a child who was at least 5 years old (also referred to as G2s). For 
the first time at wave 5 and again at wave 6, the children of all G2s (referred to as G3s; N 
= 695), their children’s “other” biological parents, and the children’s teachers were 
interviewed. At wave 5 only, G3s and their parents were invited to participate in a 
laboratory visit. Finally, three follow-up assessments were conducted after wave 6 for the 
G3s only. The first occurred 18 months after wave 6, the second occurred approximately 
three years after wave 6, and the third occurred approximately four years after wave 6. 
See Figure 2 for a visual display of the data collection timeline.  
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Sample retention across all follow-ups was excellent. 449 (99%) original 
adolescent G2s were interviewed at wave 2, 444 (98%) were interviewed at wave 3. 734 
(90%) G2s were interviewed at wave 4, 818 (91%) G2s were interviewed at wave 5, and 
816 (90%) G2s were interviewed at wave 6. Of the original 695 G3s interviewed in wave 
5, 606 (87%) G3s were interviewed in wave 6, 554 (78%) G3s were interviewed at the 
wave 6 18-month follow up, 622 (89%) G3s were interviewed at the wave 6 3-year 
follow up, and 515 (74%) G3s were interviewed at the wave 6 4 year follow up. At least 
some data were collected for 471 G3s at the wave 5 laboratory visit.  
 AFDP recruitment. COA families were recruited using court records, 
community telephone surveys, and health maintenance organization (HMO) wellness 
questionnaires. Individuals who were convicted of driving while intoxicated were 
identified by using records from seven court systems from 1985-1988. The court records 
were examined for potential indicators of alcohol problems, such as whether the 
individual had a blood alcohol content of at least 0.15 during the time of their arrest, prior 
alcohol-related arrests, a score of seven or above on the Michigan Alcohol Screening Test 
(Selzer, 1971) or a probable diagnosis of alcoholism as determined by a substance abuse 
screening center. Individuals were only invited to participate if they lived in Arizona, 
were non-Hispanic Caucasian or Hispanic, and were born between 1926 and 1960. One 
hundred and three COA families were recruited using these methods.  
 Next, HMO wellness questionnaire responses of members who had joined 
between 1986 and 1988 were screened. The questionnaires of new members who had 
been arrested between 1964 and 1988 and who met the demographic criteria mentioned 
above were examined for several indicators of alcoholism. These included whether the 
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individual self-reported having consumed 26 or more alcoholic drinks per week, 
experienced three or more alcohol-related social consequences, or whether they self-
identified as an alcoholic.  Twenty two additional COA families were recruited using 
these methods. 
 Community telephone surveys were also used to identify potential participants. 
Families who met the demographic criteria were assessed for alcoholism using several 
indicators. These included whether they attended Alcoholics Anonymous meetings, 
whether they had been hospitalized for a drinking problem, or whether they reported that 
their spouse was an alcoholic. One hundred and twenty COA families were recruited 
using these methods. One COA family was referred by a local Veteran’s Administration 
outpatient treatment program. Finally, 80 families who had been screened to participate 
as part of the demographically matched control group (see below) met diagnostic criteria 
for alcoholism and were re-classified as COA families. 
 Structured face-to-face interviews using the DIS-III (Robins, Helzer, Croughan, & 
Ratcliff, 1981) were used to directly verify whether parents had lifetime alcohol abuse or 
dependence using DSM-III criteria. These interviews were conducted with the parent 
suspected of alcoholism, when possible. However, if he/she refused to participate, his/her 
spouse reported on their lifetime alcohol abuse or dependence symptoms using the 
Family History-Research Diagnostic Criteria (FH-RDC; Endicott, Andreasen & Spitzer, 
1975). Of those interviewed, 219 biological fathers and 59 biological mothers were 
diagnosed with DSM-II lifetime alcohol abuse or dependence.  
 Reverse directories were used to recruit families who lived in the same 
neighborhoods as the recruited COA families and were matched to the COA families on 
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children’s age, family composition, ethnicity, and socioeconomic status. Non-alcoholic 
families were included if neither biological nor custodial parent met DSM-III or FH-RDC 
criteria for lifetime alcohol abuse or dependence. Seventeen of these families reported 
sub-threshold levels of lifetime alcohol abuse or dependence. These families were 
eliminated from the study to decrease the likelihood that the parent would be diagnosed 
with alcoholism later in the project. 
 AFDP recruitment biases. Two main sources of potential recruitment bias were 
observed for the larger longitudinal study. First, among the potential COA families, bias 
could have been incurred if those who were successfully contacted differed 
systematically from those who were not (Chassin, et al., 1992). Thus, the court and HMO 
records of successful contacted participants were compared to those who were not. These 
records were specifically examined because they provided archival data on potential 
participants. T-test and chi-square analyses revealed that participants who were 
successfully contacted did not differ from those who were not contacted on blood alcohol 
level at the time of arrest, number of prior alcohol-related arrests, self-identification as an 
alcohol, or MAST scores. However, those who were not successfully contacted were 
significantly more likely to be younger, to be of Hispanic ethnicity, to be unmarried, and 
to have a lower socioeconomic status (SES) compared to contacted participants. 
 Second, bias could have been incurred if those who refused to participate differed 
systematically from those who agreed. Of the families who were screened using 
telephone surveys, 73% of the COA families and 77% of the control families 
participated. Individuals from COA families who refused to participate did not differ 
from those who agreed on their age, sex, SES or alcoholism indicators. However, 
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individuals from COA families who refused to participate more significantly more likely 
to be Hispanic and married. For the control sample, no differences were found between 
those who participated vs. those who refused on family composition or SES. However, 
mothers and fathers from control families who refused to participate were more likely to 
be Hispanic than mothers and fathers from control families who agreed. For more details 
on possible biases see Chassin et al. (1992).  
 AFDP procedure. At wave 6 (hereafter referred to as T1), in-state G3 children 
and their parents were interviewed in their homes or at Arizona State University. At the 
wave 6 18-month follow up (hereafter referred to as T2) and the four-year follow-up 
(hereafter referred to as T3), children were interviewed via the telephone. At all waves, 
out-of-state children and their parents were interviewed through mailed surveys or the 
telephone. Written informed consent was obtained from parents and written informed 
assent was obtained from adolescents at every interview. These consent and assent forms 
described the nature of the interview, including that information about substance use 
would be asked, emphasized the voluntary nature of participation, and described limits of 
confidentiality.   
 AFDP genotyping. Extraction of DNA, standardization and plating were 
completed in the Department of Psychiatry at the Washington University School of 
Medicine and genotyping through the Washington University Genome Sequencing 
Center. 1536 SNPs were designed for genotyping using the Illumina Golden Gate 
technology that draws on a previous collaboration illustrated in Hodgkinson et al. (2008) 
with substitutions reflecting advances in the literature. Quality control analyses included 
examining cluster plots to rule out ambiguous genotype calls, checking for Mendelian 
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inconsistencies, incorrect gender assignments and sample swaps, cryptic relatedness, 
flagging SNPs with low call rates (<95%), and deviations from Hardy-Weinberg 
equilibrium (HWE). SNPs were removed if they had a call rate < 95%, deviated from 
HWE (p<10-6), or if they had a minor allele frequency (MAF) < 2%. In addition, 
participants whose genetic data showed Mendelian inconsistencies or were suspected of 
incorrect gender assignments, cryptic relatedness, and/or sample swaps were excluded 
from the study (N = 5). Note that cryptic relatedness refers to the presence of close 
relatives within a sample who were seemingly unrelated based on information collected 
in the study. Participants who actually were related to one another based on records were 
retained and their relatedness accounted for (see Data Analytic plan).  
Child Development Project 
 CDP participants. The second sample for the current study was drawn from a 
longitudinal, multi-site community sample (Dodge, Bates, & Pettit, 1990). Data were 
collected annually for 20 years from Nashville, TN, Knoxville, TN, and Bloomington, 
IN. These sites were demographically diverse and included rural, semi-rural, small- and 
midsize-urban communities. Families were recruited in 1987 and 1988, forming two 
cohorts of participants. The annual attrition rate is approximately 3.3%.  
 CDP recruitment. Families were randomly approached during their child’s 
kindergarten preregistration (5 years old) and asked to participate in the study. Across the 
two cohorts, 585 (75%) of the parents who were approached in this manner agreed to 
participate in the study. Of these 585 families, 477 (81.5%) were non-Hispanic 
Caucasian, 97 (16.5%) were African American, and 11 (2%) were Asian or Middle-
Eastern.  
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 CDP procedure. In the summer before children entered kindergarten, mothers 
were interviewed in their homes and filled out questionnaires regarding their child’s 
developmental history.  Each year, mothers, fathers, and children were interviewed and 
filled out questionnaires. Children’s teachers filled out questionnaires yearly. Written 
informed consent was obtained from parents and written informed assent was obtained 
from children at every interview. The current study used data from years 8 (12-13 years 
old), 10 (14-15 years old) and 11 (15-16 years old), hereafter referred to as T1, T2, and 
T3, respectively. 
CDP genotyping. The CDP sample was genotyped using the Axiom Biobank 
array, which contains rare exome/loss of function variants (~75,000), eQTLs markers 
(16,000), imputation GWAS grid (246,000 SNPs), and cSNPs and InDels Variants 
(264,000).  
The Present Study 
 AFDP participants. Data were drawn from three waves of AFDP when the 
participants were 10-17.99 (T1), 11-18.99 (T2) and 13-20.99 (T3). Further inclusion 
criteria for the AFDP sample were non-Hispanic Caucasian ethnicity (to reduce concerns 
related to population stratification), no genotyping errors or suspicion of sample swaps 
(excluded N = 5) and were genotyped (N = 254). These age restrictions were utilized to 
limit the considerable age heterogeneity within each wave and to capture the relative 
developmental period of adolescence while still maximizing the sample size. Compared 
to excluded participants, included participants were significantly younger at T1 (t = 2.75, 
p = 0.01), had significantly higher parental education (i.e., SES; t = -4.78, p < 0.001) and 
lower levels of Hispanic ancestry (t = -16.38, p < 0.001). Included and excluded 
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participants did not differ with respect to their gender, parental substance use disorder 
(SUD), T1 effortful control, T1 or T2 depressive symptoms, T1 or T2 
aggressive/antisocial behavior, or T2 or T3 alcohol problems. Of those who had genetic 
data, included and excluded participants also did not differ with regards to polygenic risk 
for serotonin functioning. The younger ages and lower levels of Hispanic ancestry of 
included compared to excluded participants were due the inclusion criteria, which aimed 
to reduce age heterogeneity and concerns of population stratification. The differences in 
SES between included and excluded participants likely reflect the inclusion of only non-
Hispanic Caucasian participants.  
 CDP participants. Data were drawn from three waves of CDP when the 
participants were in 7th grade (T1; 12-13 years old), 9th grade (T2; 14-15 years old), and 
10th grade (T3; 15-16 years old). These ages were chosen for several reasons. These age 
ranges approximately reflect the mean ages captured in AFDP so that similar 
developmental periods could be captured across studies. However, mismatch in the 
developmental periods during which constructs were assessed across both studies was 
unavoidable because AFDP has considerable age heterogeneity within waves, while CDP 
has very little age heterogeneity within waves. In addition, the age ranges chosen in CDP 
were dictated in part by measure availability. The only CDP measure that adequately 
reflects effortful control was measured when participants were in 7th grade. Moreover, the 
latest alcohol use assessment was administered in 10th grade. This was also the only 
alcohol use assessment that was measured at two waves to allow prospective prediction. 
Note that although an alcohol problems measure was administered one year after high 
school, many of the participants were in college by that time. Because alcohol use in 
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college is theoretically different from alcohol use initiated in adolescence, we chose not 
to use this measure to facilitate reproducibility across the samples.   
Further inclusion criteria for the CDP sample were that participants were non-
Hispanic Caucasian (to reduce concerns related to population stratification) and had 
genetic data (N = 348). Compared to excluded participants, included participants had 
significantly higher SES (t = -6.85, p < 0.001) and significantly lower T1 conduct 
problems (t = 2.79, p < 0.01). Included and excluded participants did not differ 
significantly with respect to their gender, parental alcohol problems, T1 
conscientiousness, T1 or T2 depressive symptoms, T2 aggressive/antisocial behaviors, or 
T2 or T3 alcohol use. The differences in SES between included and excluded participants 
likely reflect the inclusion of only non-Hispanic Caucasian participants. Note that genetic 
data were only obtained for included participants and, therefore, no comparisons to 
excluded participants could be made. 
Measures 
Descriptive statistics for all variables are shown in Table 1. Correlations among 
all variables for AFDP are shown in Table 2 and for CDP in Table 3.  
Demographic information. In both studies, adolescents self-reported their 
gender, age, and ethnicity. Gender was dummy coded such that 0 represented females and 
1 represented males. Only children who self-identified as non-Hispanic Caucasian were 
included in both samples to reduce concerns that population stratification confounded 
results. The CDP analyses did not use age as a covariate because all children were 
virtually the same age at each wave. 
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Socioeconomic status (SES). The highest level of education achieved by the 
adolescents’ mother or father indexed SES in both the AFDP and CDP samples and was 
used as a continuous covariate. This variable has been shown by previous researchers to 
be the most stable and sensitive indicator of SES risk for adolescents (Krieger, Williams, 
& Moss; Williams & Collins, 1995).  
At T1 in AFDP, parents self-reported their highest level of education [1 = 8th 
grade or less, 2 = some high school, 3 = GED (high school equivalency diploma), 4 = 
high school graduate, 5 = some vocational or technical school, 6 = completed vocational 
or technical school, 7 = some college, 8 = AA degree (2 year college), 9 = BA or BS (4 
year college degree), 10 = some graduate or professional school, 11 = completed 
graduated or professional school). In this sample, 0.4% completed 8th grade or less, 3.2% 
completed some high school, 2.8% completed a GED, 6.9% completed high school, 2.4% 
completed some vocational or technical school, 6.5% completed vocational or technical 
school, 27.0% completed some college, 15.7% completed an Associate’s degree, 21.4% 
completed a 4 year college degree, 1.6% completed some graduate or professional 
school, and 12.1% completed graduate or professional school. Overall, the sample was of 
moderate levels of SES, given that parents on average completed some college or an 
associate degree.  
In CDP, parents self-reported their highest level of education [1 = 1-6 years, 2 = 
7-9 years, 3 = 10-11 years, 4 = 12 years, 5 = 13-15 years, 6 = 16-17 years, 7 = 18+ years]. 
In this sample, 0.6% of parents’ obtained 7-9 years of education, 2.9% had 10-11 years 
of, 30.7% had 12 years, 19.0% had 13-15 years, 27.8% had 16-17 years, and 19% had 18 
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or more years. Overall, the sample was of moderate levels of SES, given that parents on 
average completed 13-15 years of education. 
Parent substance use disorder (SUD).  At T1 in AFDP, adolescents’ biological 
parents reported their lifetime alcohol/drug abuse or dependence by DSM-IV criteria 
using the Computerized Diagnostic Interview Schedule (C-DIS; Robins et al., 2000). 
Spousal reports of the Family History Research Diagnostic Criteria (Endicott, Andreasen, 
& Spitzer, 1975) were used for non-interviewed parents. Adolescents were classified as 
having a parent with an SUD if one biological parent had a lifetime alcohol or drug 
disorder. This measure was used as covariate in the AFDP analyses. 54.9% of adolescents 
had at least one parent with an SUD, demonstrating the high-risk nature of this sample.  
During the 12th year of the CDP study (11th grade), adolescents’ parents reported 
their lifetime alcohol problems [0 = no, 1 = yes] using 12 problem drinking items from 
the Short Michigan Alcohol Screening Test (MAST; Selzer, Vinokur, & van Rooigen, 
1975). These items were summed for each parent. Cronbach’s alpha was 0.82 for fathers’ 
alcohol problems and 0.67 for mothers’ alcohol problems. The highest alcohol problem 
score across mother and father was used to represent parents’ alcohol problems. Although 
it would have been ideal to utilize a measure of parents’ lifetime alcohol problems that 
was assessed prior to or at the same wave as adolescents’ temperament and/or problem 
behaviors, these data were not available in the CDP. This measure was used as a 
covariate in the CDP analyses. Overall, adolescents’ parents had low levels of lifetime 
drinking problems, given that parents reported only 1.71 alcohol problems in their 
lifetime on average and 54.5% of the adolescents’ parents reported no lifetime alcohol 
problems.  
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Adolescent ancestry. Thirty-seven of the SNPs genotyped in the AFDP dataset 
are ancestry informative markers. Previous research demonstrated that these SNPs 
distinguished between non-Hispanic Caucasian and Mexican/Mexican-American ancestry 
(Tian, Gregersen, & Seldin, 2008). The two most represented ethnic groups in this sample 
and in Arizona are Non-Hispanic Caucasian and Mexican/Mexican-American. It is 
important to include ancestry as a covariate in analyses despite the inclusion of only self-
identified non-Hispanic Caucasian participants. This is because there is likely population 
admixture between non-Hispanic Caucasian and Mexican/Mexican-American individuals 
in this sample due to geographical location.  
A principal components analysis was performed on these SNPs. Results indicated 
that the first component explained 18.99% of the variance (eigenvalue = 7.03), the second 
explained 3.36% (eigenvalue = 1.24), and the third explained 3.11% (eigenvalue = 1.02). 
32 SNPs that had loadings greater than 0.30 on the first principal component were used as 
indicators of a one-factor model using maximum likelihood estimation. The model fit the 
data well: 2(464) = 824.99, p < 0.001, RMSEA = 0.03, CFI = 0.94, SRMR = 0.03. 
Factor scores were saved and used a covariate in the analyses. These scores were highly 
correlated with adolescents’ self-reported ethnicity in the combined non-Hispanic 
Caucasian and Mexican/Mexican-American sample (r = -0.83, p < 0.001), confirming 
their validity. Higher factor scores indicate higher levels of Caucasian (as opposed to 
Mexican/Mexican-American) ancestry. A measure of genetic ancestry was unavailable for 
the CDP sample.  
Adolescents’ prescription medication use. At T1 in AFDP, parents reported on 
whether their child was currently taking any prescription medications other than 
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antibiotics or allergy medication (1 = Yes, 0 = No). 14.7% of adolescents were currently 
taking prescription medications. This was used as a covariate to ensure that psychotropic 
medication use did not confound or obscure the relation between polygenic risk and 
outcomes. Note that this variable was unavailable in CDP. 
Time between assessments. The time between assessments was calculated for 
use as a covariate in AFDP analyses. This is because the time between T1 and T2, and 
between T2 and T3, was not uniform across participants, and participants were also 
heterogeneous in age (see Table 1 for descriptive statistics). For example, a participant 
with a shorter period of time in between their T2 and T3 assessments may not exhibit as 
much drinking behavior at T3 when compared to a same-aged participant with a longer 
period of time between their T2 and T3 assessments. Controlling for this variable may 
further elucidate paths of interest, especially to alcohol use. The same was not done for 
CDP because there was much less heterogeneity in time between assessments, given that 
participants were assessed annually by grade. 
Polygenic risk score. A polygenic risk score indexing 5-HIAA (serotonin 
metabolite) concentrations in the cerebrospinal fluid was created in both AFDP and CDP. 
Greater scores on the polygenic risk score index one’s presumed genetic risk for lower 
levels of serotonin functioning (hereafter referred to as the 5-HT polygenic risk score for 
simplicity). Results were drawn from a GWAS that examined 414 participants from 
outpatient preoperative screening services in four hospitals in the Netherlands (Luykx et 
al., 2014). Participants were included if they were 18-60 years old, had four grandparents 
born in the Netherlands, Belgium, Germany, United Kingdom, France, and Denmark (i.e., 
of European ancestry), and were undergoing spinal anesthesia for minor elective 
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surgeries. Patients were excluded from the study if they had a history of psychotic or 
major neurological disorders or if they were not of European ancestry as determined by 
genetic analyses. Six ml of CSF were obtained from each participant and concentrations 
of 5-HIAA were measured using high-performance liquid chromatography and 
electrochemical detection. Genotyping was performed using the Illumina 
HumanOmniExpress Beadchip (730,525 SNPs). Relevant covariates were included in the 
GWAS computation (see Luykx et al., 2014 for details).  
1191 SNPs were genotyped in both AFDP and Luykx et al. (2014)’s study. Of 
these 1191 SNPs, 1119 SNPs were genotyped in CDP. The current study drew from these 
overlapping SNPs to create 5-HT polygenic risk scores in both AFDP and CDP. This 
study analyzed a smaller number of SNPs in the CDP despite the availability of GWAS 
data to achieve the greatest possible concordance between AFDP and CDP analyses and 
to facilitate replication.  
To prepare the data, quality control and data preparation steps were performed. 
For instance, during the genotyping process, some genes are read on the forward strand 
while others are read on the reverse strand. Thus, it is possible that some genes were read 
on the forward strand in the GWAS but on the reverse strand in AFDP or CDP. For non-
palindromic SNPs (i.e., not C/G or A/T SNPs), these strand issues are typically easily 
reconciled because it is always the case that A binds with T (e.g., A on the forward strand 
corresponds to T on the reverse strand and vice versa) whereas C binds with G. Thus, if 
the GWAS specified their reference allele as ‘A’, but our study genotyped ‘C’ and ‘T’ 
alleles, it would be clear that the reference allele for our SNP should be specified as ‘T’. 
When observed, these types of strand issues were reconciled. However, palindromic 
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SNPs (i.e., C/G and A/T SNPs) that have MAFs > 45% might be difficult to reconcile 
with respect to which is the reference allele (Arpana Agrawal, personal communication). 
Therefore, any C/G or A/T SNPs with MAFs > 45% were deleted.  SNPs that were in 
strong linkage disequilibrium with another SNP were pruned to ensure that the score 
represented the effect of independent (not redundant) SNPs. A pairwise r2 threshold of 
0.25 within a 200-SNP sliding window was employed using the PLINK command, –
indep-pairwise 200 5 .25, based on recommendations by Purcell et al. (2009).  
Currently, there are no firmly established criteria for using GWAS results to create 
polygenic risk scores or for choosing the GWAS p-value threshold to create maximally 
informative polygenic risk scores. Including only those SNPs that pass the genome-wide 
significance threshold in the discovery GWAS will likely fail to capture the polygenicity 
of the trait, especially because GWAS are typically underpowered. Some researchers 
created polygenic risk scores by including SNPs that passed an a priori liberal threshold 
of p < 0.50 in the GWAS discovery sample (Hamshere et al., 2013; Purcell et al., 2009). 
However, another more recent study suggested that this threshold could be too liberal 
(Evans et al., 2013) because it increased the likelihood of spurious associations due to the 
pleiotropic effects of many SNPs and increased the chance of Type I error for certain 
constructs (Evans et al., 2013). Therefore, Evans and colleagues suggested employing the 
strictest p-value threshold from the GWAS discovery set that maximizes the amount of 
variance explained in the construct it was created to index. Unfortunately, however, 
neither AFDP nor CDP measured serotonin functioning. Furthermore, it is likely not a 
defensible approach to choose the significance threshold by creating polygenic risk 
scores using the GWAS test-statistics and p-value thresholds and then examining how 
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much variance they explain in the very same CSF 5-HIAA scores that were used to create 
the polygenic risk scores. Any spurious associations arising from idiosyncrasies in the 
GWAS sample would appear to contribute meaningfully to the phenotype, and therefore 
may bias the selection of the polygenic risk score p-value threshold. Likewise, examining 
which p-value threshold maximizes the variance in the current study variables would also 
not be defensible due to its reliance on circular reasoning (e.g., testing whether polygenic 
risk for serotonin functioning predicts alcohol use by choosing the genetic risk score that 
best predicts alcohol use).   
Therefore, the current study included SNPs in the 5-HT polygenic risk score if 
they passed a significance threshold of p < 0.05 in the GWAS discovery set (Agrawal, 
personal communication). Although this threshold is more liberal than typical genome-
wide significance thresholds, it may better capture the polygenicity of serotonin 
functioning. This may be especially true since the current GWAS was underpowered due 
to a relatively small sample size (N = 414). However, a threshold of p < 0.05 is also less 
likely than the liberal threshold of p < 0.50 to reflect spurious associations. Finally, by 
choosing a threshold of p < 0.05 a priori, we further reduce the likelihood of chance 
findings. Of those SNPs that met the p < 0.05 threshold, only those that were genotyped 
in both AFDP and CDP (23 SNPs) were used to facilitate replication. Thus, a 5-HT 
polygenic risk score using 23 SNPs that were associated with CSF 5-HIAA levels at p < 
0.05 were created by weighting the number of risk alleles for each SNP by its GWAS 
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test-statistic and averaging these figures1.  See Table 4 for a list of the SNPs included in 
the AFDP and CDP polygenic risk scores.  
Methods for addressing item overlap between effortful control and 
adolescent symptomatology. Temperament/personality and psychopathology measures 
often contain item overlap (Lemery, Essex, & Smider, 2002). Therefore, preliminary 
analyses were conducted in order to reduce potential confounding of AFDP temperament 
and psychopathology measures using previously established methods by Eisenberg and 
colleagues (e.g., Eisenberg et al., 2004). Specifically, 16 expert raters (8 faculty 
members, 6 post-doctoral fellows and 2 graduate students) rated each problem behavior 
and temperament item used in the current study using a questionnaire that asked the 
extent to which each item reflected either temperament or psychopathology [1 = Much 
better measure of temperament than symptoms, 3 = Not a better measure of temperament 
or symptoms, substantial content for both, 5 = Much better measure of symptoms than 
temperament]. Scores were averaged across each item. Effortful 
control/conscientiousness items with an average score greater than 3 (rated as a better 
measure of symptoms than temperament) were deleted. Problem behavior items with an 
average score less than 3 (rated as a better measure of temperament than symptoms) were 
deleted. Using this procedure, it was found that no temperament or problem behavior 
items should be deleted and all items were retained for the analyses. See Appendices A-C 
for all the effortful control and symptomatology items used in AFDP and CDP.  
                                                 
1 Another approach to creating polygenic risk scores is to unit-weight the SNPs and take their average. The 
unit-weighted polygenic risk scores were correlated very highly and significantly with the test-statistic 
weighted polygenic risk scores (rAFDP = 0.99, p < 0.001; rCDP = 0.99, p < 0.001). Very similar results would 
likely be obtained using either score. Therefore, the test-statistic weighted polygenic risk scores were used 
in all analyses. 
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T1 effortful control. In AFDP at T1, mothers, fathers, and adolescents reported 
[1 = almost always untrue; 5 = almost always true] on adolescents’ effortful control using 
the attentional control, activation control, and inhibitory control subscales of the Early 
Adolescent Temperament Questionnaire (EATQ; Capaldi & Rothbart, 1992). These 
subscales were averaged to form mother-, father-, and adolescent-reported composite 
scales of effortful control. Cronbach’s alpha for mother-, father-, and adolescent-reported 
effortful control were 0.83, 0.91, and 0.91, respectively. Mother-, father-, and adolescent-
reported effortful control composites were used as indicators of a one-factor model in 
Mplus v. 7.2 (Muthén & Muthén, 1998-2012) using maximum likelihood estimation with 
robust standard errors. Model fit was not available because the model was just-identified. 
However, standardized factor loadings for mother-, father-, and adolescent-reported 
effortful control were significant (p < 0.001) and high, ranging from 0.64-0.86. Effortful 
control factor scores were saved in Mplus to reduce complexity and used in all 
subsequent analyses.  
In CDP at T1, adolescents self-reported [1 = hardly at all, 5 = extremely much] 
their conscientiousness using a shortened version of the Big Five Personality 
Questionnaire (Costa & McCrae, 1992). Conscientiousness involves emotional and 
behavioral control (Shiner & Caspi, 2003), is associated with effortful attention (Rothbart 
& Ahadi, 1992) and has been theorized to be the dimension of personality that 
corresponds to the effortful control superfactor of temperament (Ahadi & Rothbart, 
1994). Furthermore, in a review of the literature, Eisenberg, Duckworth, Spinrad, and 
Valiente (2014) argued that effortful self-regulation in childhood fosters 
conscientiousness later in life. Based on this information, this measure of 
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conscientiousness may reflect effortful control (note that the CDP did not have a measure 
of effortful control). These items were averaged to form an adolescent-reported measure 
of conscientiousness. Cronbach’s alpha was 0.63. Unfortunately, no other raters reported 
on adolescents’ conscientiousness and therefore a multiple reporter model of 
conscientiousness was not possible.  
T1 and T2 symptomatology. In both AFDP and CDP, adolescents’ reports of 
their symptomatology were chosen for several reasons. First, only adolescents reported 
on the same symptomatology items at two different waves in AFDP which allowed for 
longitudinal prediction in both samples. Second, research suggests that adolescents may 
be more informative reporters of behaviors intentionally hidden from parents, such as 
rule-breaking behaviors.  Third, adolescents are considered more valid reporters of their 
depressive symptoms than are parents (Grills & Ollendick, 2002).  
At T1 and T2 in both AFDP and CDP, adolescents self-reported [0 = Not True, 2 = 
Somewhat True, 3 = Very True/Often True] their aggressive/antisocial behaviors and 
depressive symptoms using the DSM-oriented Conduct Problems Scale and Affective 
Problems scale from the CBCL (Achenbach & Rescorla, 2001). The 15 
aggressive/antisocial behavior items reported during T1 and T2 were summed to form 
two separate composites representing adolescents’ aggressive/antisocial behaviors at T1 
or T2. In AFDP, Cronbach’s alpha for these measures was 0.82 at T1 and 0.82 at T2. In 
CDP, Cronbach’s alpha was 0.72 at T1 and 0.75 at T2. The depressive symptom items 
reported during T1 and T2 were summed to form two separate composites representing 
adolescent depressive symptoms at T1 or T2. In AFDP, Cronbach’s alpha for the 13-item 
measures was 0.79 at T1 and 0.81 at T2. In CDP, Cronbach’s alpha for the 12-item 
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measures was 0.66 at T1 and 0.77 at T2 (note that one item, “There is very little that I 
enjoy” was not assessed in CDP but was assessed in AFDP). Adolescents’ self-reported 
problem behaviors at T1 were used as covariates in predicting the corresponding problem 
behavior at T2 to allow for prospective prediction. On average, AFDP and CDP 
participants had low-to-moderate levels of symptomatology. 
T3 alcohol use. In AFDP at T2 and T3, adolescents self-reported [0 = Never; 1 = 
1-2 times; 2 = 3-5 times; 3= More than 5 times but less than once a month; 4 = 1-3 times 
per month; 5 = 1-2 times per week; 6 = 3-5 times per week; 7 = Every day] how often 
they drank alcohol in the past year. Adolescents’ self-reported alcohol use at T2 was used 
as a covariate in predicting their self-reported alcohol use at T3 to allow for prospective 
prediction. 74.4% of participants had never used alcohol at T3. 
In the CDP at T2 and T3, adolescents self-reported [0 = Never; 1 = Once in a 
while; 2 = Sometimes; 3 = Fairly often; 4 = Very often] how often they drank alcohol in 
the past year. Adolescents’ self-reported alcohol use at T2 (9th grade) was used as a 
covariate in predicting their self-reported alcohol use at T3 (10th grade) to allow for 
prospective prediction. 66.4% of participants had never used alcohol.  
Data from the Monitoring the Future study showed that 76.5% of 10th graders had 
not had an alcoholic beverage in the past 30 days (Monitoring the Future 2014 Survey 
Results, 2014). Assuming that alcohol use in the past 30 days is at least somewhat 
reflective of alcohol use in the past year, this suggests that the frequency of past year 
alcohol use in both the AFDP and CDP samples are fairly age-typical. An alcohol 
frequency variable was selected for use in both samples because it provides the best 
concordance across studies in terms of content and ages of assessment, thus facilitating 
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reproducibility. Moreover, this was the only alcohol use variable in the CDP data that 
was assessed at multiple time points. Adolescents’ self-reports of alcohol use were 
chosen because research shows that parents tend to be less accurate reporters of 
adolescents’ alcohol use (Fisher et al., 2006).  
Data Analytic Plan 
AFDP-specific information. Analyses for AFDP were conducted in Mplus v.7.2 
(Muthén & Muthén, 1998-2012) using maximum likelihood with robust standard errors 
and full information maximum likelihood to estimate missing data which provide 
unbiased estimates when data are missing completely at random (MCAR) or missing at 
random (Schafer & Graham, 2002; N = 254). Little’s MCAR test suggested that the data 
were MCAR (2(59) = 66.34, p = 0.24). Because participants are nested within families, 
the TYPE=COMPLEX function in Mplus was used to account for the non-independence 
of the data. Covariates included adolescents’ age, ancestry, SES, parent SUD, time 
between assessments, prescription medication use, T1 aggressive/antisocial behaviors and 
depressive symptoms (symptomatology), and T2 alcohol use. Predictor variables 
included adolescent gender (hypothesized moderator), 5-HT polygenic risk, T1 effortful 
control, and T2 symptomatology. T3 alcohol use was the outcome variable.  
CDP-specific information. Analyses for CDP were conducted in Mplus v.7.2 
(Muthén & Muthén, 1998-2012) using maximum likelihood with robust standard errors 
and full information maximum likelihood to estimate missing data (N = 348). Little’s 
MCAR test suggested that the data were MCAR (2(25) = 32.08, p = 0.16). Covariates 
included SES, parents’ alcohol problems, T1 symptomatology, and T2 alcohol use. 
Predictor variables included adolescents’ gender (hypothesized moderator), 5-HT 
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polygenic risk, T1 conscientiousness, and T2 symptomatology. T3 alcohol use was the 
outcome variable.  
Data plan common to both samples. Paths were estimated from all covariates 
and the 5-HT polygenic risk score to all mediators (T1 effortful control/conscientiousness 
and T2 symptomatology) and the outcome variable (T3 alcohol use). Next, paths were 
estimated from T1 effortful control/conscientiousness to T2 symptomatology and T3 
alcohol use. Paths were also estimated from adolescents’ T2 symptomatology to their T3 
alcohol use. Autoregressive paths from T1 to T2 symptomatology and from T2 to T3 
alcohol use were also estimated. Note that this allowed prospective prediction of these 
constructs at T2 and T3, respectively. Correlations among all exogenous variables were 
modeled. In addition, within-wave correlations among T1 symptomatology measures and 
T1 effortful control/conscientiousness as well as among T2 symptomatology measures 
and T2 alcohol use were modeled.  
A separate set of analyses tested this same model except without the 
autoregressive paths of T2 symptoms on T1 symptoms and of T3 alcohol use on T2 
alcohol use. These analyses were conducted to examine whether genetic influences on 
change in symptoms over time (i.e., with autoregressive paths) differed from genetic 
influences on more trait-like measures of symptoms (i.e., without autoregressive paths). 
Note that it was not of primary interest whether the effects of other predictors changed 
after removing autoregressive paths. 
Preliminary analyses determined which predictor-by-covariate and predictor-by-
predictor interactions to include in the final models. Although predictor-by-covariate 
interactions were not hypothesized, they were still tested by entering their cross-products. 
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Indeed, it would be incorrect to assume that genetic effects are necessarily constant 
across age or SES. The exception was that gender-by-covariate interactions were not 
tested since gender is only considered a predictor due to its hypothesized moderating 
influence on the main paths of interest. Due to their non-hypothesized nature, predictor-
by-covariate interactions were only retained if they survived a false-discovery rate (FDR) 
correction p < 0.05 using SAS (fdr option). FDR corrections were chosen because they 
have greater power to detect truly significant results, are less conservative than 
Bonferroni corrections, and still maintain adequate control of Type 1 error (Shaffer, 
1995). If a polygenic risk-by-covariate interaction survived the FDR correction, all 
polygenic risk-by-covariate and covariate-by-covariate interactions were included in the 
model to ensure that the interaction effect was not driven by confounding variables, as 
recommended by Keller (2014). Any significant interactions involving the 5-HT 
polygenic risk score were also re-tested following monotone transformations of the 
interacting variables to ensure that results were not due to scaling-related spuriousness 
(Young-Wolff, Enoch, & Prescott, 2011). 
Gender was considered a predictor in the current study due to its relevance to 
hypothesis testing. The hypothesized predictor-by-gender interactions were tested by 
entering their cross-products and retained if their p < 0.05. If a polygenic risk-by-gender 
interaction was significant, all polygenic risk-by-covariate and gender-by-covariate 
interactions were included to ensure that the interaction effect was not driven by 
confounding variables (Keller, 2014). In addition, any significant interactions involving 
the polygenic risk score were re-tested following monotone transformations of the 
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interacting variables to ensure that results are not due to scaling-related spuriousness 
(Young-Wolff, Enoch, & Prescott, 2011).  
Nonessential multicollinearity was reduced by centering all predictors and 
covariates prior to computing interaction terms. Interaction effects were tested using 
simple slope analyses (Aiken & West, 1991). The joint significance test was used to test 
two- and three-path mediated effects. The joint significance test requires each of the paths 
in the mediated effect to be significant for the overall mediational effect to be significant. 
This approach has been suggested by previous researchers to be a good approach for 
balancing Type 1 error and statistical power for both two- and three-path mediated effects 
(MacKinnon, Lockwood, Hoffman, West & Sheets, 2002; Taylor, MacKinnon, & Tein, 
2007). If any paths in the mediational chain were moderated by gender or demographic 
variables, moderated mediation was tested. To do so, simple slope analyses were 
conducted to probe each link in the mediational chain by relevant moderators.  
Because the T3 alcohol use outcome measures were zero-inflated variables in 
both AFDP (74.4%) and CDP (66.4%), preliminary analyses determined the best 
modeling strategy. Models estimating only the effects of covariates on T3 alcohol use 
were conducted, with alcohol use alternatively specified as either a zero-inflated poisson, 
zero-inflated negative binomial, continuous, or categorical variable. The modeling 
procedure producing the lowest Akaike Information Criteria (AIC), Bayesian Information 
Criteria (BIC) and the highest -2 log likelihood was chosen.  
All variables were examined for out of range values. Model diagnostics were 
performed for all analyses to identify outliers and influential cases. Cook’s D, which 
measures the influence of an observation on the parameter estimates, and DFBETAS, 
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which measures the standardized change in the regression coefficient when a case is 
deleted, were used to identify influential cases (Cohen et al., 2003; Cook, 1977). 
Research suggests that cases with a Cook’s D or DFBETAS greater than an absolute 
value of one may be influential for moderately sized datasets (Neter, Wasserman, & 
Kutner, 1989). For cases that may be influential or may be outliers, interview notes were 
examined to isolate potential explanations. Cases that could be reasonably excluded using 
these interview notes were dropped.  
There was sufficient power (> 0.80) to detect small effect sizes (f2 =.03) in the full 
samples of AFDP and CDP. With regards to gender moderation, there was sufficient 
power (> 0.80) to detect small-moderate effect sizes (f2 =.10) for both female and male 
groups in AFDP and to detect small-moderate effect sizes (f2 =.05) for both female and 
male groups in CDP.  
Results 
Zero-Order Correlations Among Study Variables 
AFDP. In accordance with hypotheses, adolescents with higher levels of 5-HT 
polygenic risk (i.e., lower serotonin functioning) had higher levels of T2 
aggressive/antisocial behaviors, T2 depressive symptoms, and T2 and T3 alcohol use. 
Note that 5-HT polygenic risk was not significantly correlated with effortful control. 
Adolescents with lower levels of T1 effortful control had higher levels of T1 and T2 
symptomatology and T2 and T3 alcohol use. All of the symptomatology and alcohol use 
variables were significantly correlated in the expected direction.  
Regarding correlations with demographic variables, females were more likely to 
have a parent with an SUD and had higher levels of effortful control and T2 depressive 
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symptoms when compared to males. Older adolescents and adolescents with higher levels 
of Mexican/Mexican-American ancestry had higher levels of symptomatology and 
alcohol use at most waves. Unexpectedly, older adolescents also had higher levels of 
Mexican/Mexican-American ancestry and higher levels of 5-HT polygenic risk. 
However, 5-HT polygenic risk and ancestry were not significantly correlated. 
Adolescents whose parents had SUDs had lower levels of SES and effortful control and 
higher levels of symptomatology and alcohol use at most waves when compared with 
adolescents whose parents did not have SUDs. Adolescents with lower levels of SES had 
higher levels of T2 alcohol use.  
CDP. Contrary to hypotheses, adolescents with higher levels of 5-HT polygenic 
risk had lower levels of T3 alcohol use. However, adolescents with higher levels of 5-HT 
polygenic risk also had marginally significantly higher levels of T1 aggressive/antisocial 
behaviors. No other significant correlations with 5-HT polygenic risk were found. 
Adolescents with higher levels of T1 conscientiousness had lower levels of T1 and T2 
symptomatology, but this trait was uncorrelated with alcohol use. In general, all of the 
symptomatology and alcohol use variables were significantly correlated in the expected 
direction, except T1 depressive symptoms did not significantly correlate with T2 or T3 
alcohol use and T1 aggressive symptoms did not significantly correlate with T3 alcohol 
use.  
Regarding correlations with demographic variables, females had higher levels of 
conscientiousness and T1 and T2 depressive symptoms, and lower levels of T1 and T2 
aggressive/antisocial behavior when compared with males. Adolescents with lower levels 
of SES had higher levels of parental alcohol problems (marginal). Finally, adolescents 
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with higher levels of parental alcohol problems had higher levels of T1 
aggressive/antisocial behaviors and T3 alcohol use. 
Outliers  
Cook’s D and DFBETAS were calculated in an OLS regression framework. No 
cases had a Cook’s D or DFBETAS value that exceeded an absolute value of one. No 
influential cases were identified or removed. 
Multicollinearity 
 The variance inflation factor (VIF) was calculated for each independent variable 
in both AFDP and CDP to ensure that model estimates were not unreliable or unstable 
due to one or more independent variable(s) being linear combinations of other 
independent variables. VIFs exceeding 7 were considered indicative of multicollinearity 
(Neter, Wasserman, & Kutner, 1989). All VIFs from both AFDP and CDP ranged from 
1.01-2.76. Thus, it was concluded that multicollinearity was not an issue and no 
predictors were removed from the models.  
Determining the Appropriate Modeling Strategy for Alcohol Use Outcomes 
The AIC, BIC, and log-likelihoods of covariate-only models that alternatively 
specified the T3 alcohol use outcomes as zero-inflated poisson, zero-inflated negative 
binomial, categorical, or continuous variables demonstrated that both AFDP and CDP 
alcohol use outcomes should be modeled as categorical variables. See Table 5 for the 
relative fit indices of each modeling strategy. Because all analyses modeled alcohol use 
as a categorical variable, montecarlo integration was used. Absolute fit indices are not 
available for models using montecarlo integration.  
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AFDP Results 
 Preliminary analyses to determine predictor-by-gender and predictor-by-
covariate interactions.  No predictor-by-gender interactions were significant (p < 0.05) 
and were trimmed. The T2 depressive symptoms-by-ancestry and T2 depressive 
symptoms-by-SES interactions survived the FDR-corrected p < 0.05. All interaction 
terms were included in the final model in a separate block so that main effects could be 
examined prior to the addition of interaction terms. Simple slopes were probed at the 1 
SD below the mean, at the mean, and 1 SD above the mean for continuous variables 
(referred to as low, mean, and high levels, respectively). Standardized regression 
coefficients are reported to describe the simple slopes of significant interaction effects. 
Results from the final AFDP model are organized by outcome. See Table 6 and Figure 3. 
 T1 effortful control. 5-HT polygenic risk did not predict effortful control.2 
Males, adolescents whose parents had SUDs, and adolescents who took prescription 
medication had lower levels of effortful control.   
 T2 aggressive/antisocial behaviors. Higher levels of 5-HT polygenic risk 
predicted higher levels of T2 aggressive/antisocial behaviors. Lower levels of T1 effortful 
control prospectively predicted higher levels of T2 aggressive/antisocial behaviors. 
                                                 
2 In AFDP, mother, father, and teacher-reported measures and observer ratings of effortful control were 
collected at an earlier wave occurring about 5 years before T1. Additional analyses tested whether a latent 
factor of effortful control including the current T1 effortful control measures and the effortful control 
measures collected 5 years prior were predicted by the polygenic risk score. This factor might better 
capture “trait” effortful control. This model fit the data well (χ2 (18) = 19.5, p = 0.36, RMSA=0.02, 
CFI=1.0, SRMR=0.05). The polygenic risk score did not predict this more “trait-like” measure of effortful 
control. Analyses also tested whether the polygenic risk score would relate more strongly with any specific 
sub-dimension of effortful control (i.e., attentional control, activation control, inhibitory control). The 
polygenic risk score did not significantly correlate with any of the child-, mother-, father-, teacher-, or 
observer-rated sub-dimensions of effortful control. 
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Adolescents whose parents had SUDs and who had higher levels of T1 
aggressive/antisocial behaviors had higher levels of T2 aggressive/antisocial behaviors.  
 T2 depressive symptoms.  Higher levels of 5-HT polygenic risk predicted higher 
levels of T2 depressive symptoms. Lower levels of T1 effortful control prospectively 
predicted higher levels of T2 depressive symptoms. Females, adolescents whose parents 
had SUDs, adolescents who were taking prescription medications, and those who had 
higher levels of T1 depressive symptoms had higher levels of T2 depressive symptoms.  
 T3 alcohol use. Higher levels of 5-HT polygenic risk predicted higher levels of 
T3 alcohol use. Effortful control did not predict alcohol use over and above polygenic 
risk, depressive symptoms, and aggressive/antisocial behaviors (note, however, that there 
was a significant zero-order correlation between effortful control and alcohol use). 
Higher levels of T2 aggressive/antisocial behaviors prospectively predicted higher levels 
of T3 alcohol use. T2 depressive symptoms did not have a main effect on T3 alcohol use. 
Older adolescents, adolescents who parents had SUDs (marginal), and adolescents with a 
greater lapse between T2 and T3 had higher levels of T3 alcohol use.  
The significant depressive symptoms-by-SES and depressive symptoms-by-
ancestry interaction terms were entered in a second block. The patterns of the interactions 
were such that lower levels of depressive symptoms predicted greater levels of T3 
alcohol use at mean (β = -0.22, p = 0.01) and low levels of SES (β = -0.38, p < 0.001) and 
mean (β = -0.22, p = 0.01) and low levels of ancestry (β = -0.32, p < 0.001; i.e., greater 
levels of Mexican/Mexican American ancestry). However, depressive symptoms did not 
predict alcohol use at high levels of SES (β = -0.03, p = 0.69) or high levels of ancestry 
(β = -0.12, p = 0.14; i.e., greater levels of Caucasian ancestry). See Figures 5 and 6.  
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 Models omitting autoregressive paths. The 5-HT polygenic risk score did not 
predict any outcomes differently after removing autoregressive paths.  
 Models omitting parental SUD. Having a parent with an SUD likely confers 
greater genetic and environmental risk for offspring SUD. Because it was possible that 
including parents’ SUD as a covariate weakened the effects of polygenic risk on 
outcomes, we ran models that omitted parental SUD as well. The 5-HT polygenic risk 
score did not predict any outcomes differently after removing autoregressive paths. 
 Mediation. 5-HT polygenic risk significantly and indirectly predicted T3 alcohol 
use through T2 aggressive/antisocial behaviors (both a and b paths were significant). T1 
effortful control significantly and indirectly predicted T3 alcohol use through T2 
aggressive/antisocial behaviors. See Figure 3.    
Because T2 depressive symptoms was moderated by SES and ancestry in 
predicting T3 alcohol use, simple slope analyses tested the a and b paths at low, mean, 
and high levels of these moderators. For instance, 5-HT polygenic risk had a main effect 
on depressive symptoms, and depressive symptoms predicted T3 alcohol use at certain 
levels of SES. Thus, to examine at which levels of SES this mediational chain significant, 
a polygenic risk-by-SES interaction term was included in predicting T2 depressive 
symptoms. By running analyses while centering SES at 1 SD below the mean, at the 
mean, or at 1 SD above the mean, both main effect paths in this mediational chain would 
now refer to the effect for adolescents with low SES, mean SES, and high SES, 
respectively. This procedure was completed for all possible mediational effects and 
moderators by re-centering each of the continuous moderating variables at 1 SD above 
and below the mean and at the mean (see Table 8). 
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These analyses indicated that greater polygenic risk significantly and indirectly 
predicted lower T3 alcohol use through greater T2 depressive symptoms, but only for 
adolescents with low and mean levels of SES and ancestry. In addition, greater effortful 
control significantly and indirectly predicted lower T3 alcohol use through greater T2 
depressive symptoms, but only for adolescents with low and mean levels of SES and with 
mean levels of ancestry.  
CDP Results 
 Preliminary analyses to determine predictor-by-gender and predictor-by-
covariate interactions.  Gender interacted (p < 0.05) with T2 aggressive/antisocial 
behaviors and depressive symptoms to prospectively predict T3 alcohol use. 3 SES 
interacted (FDR corrected p < 0.05) with 5-HT polygenic risk and with conscientiousness 
to predict both T2 depressive symptoms and aggressive/antisocial behaviors. 
Additional analyses tested the robustness of interactions involving the 5-HT 
polygenic risk score. Interactions with 5-HT polygenic risk were still significant after 
adding the extra interaction terms recommended by Keller (2014) and applying 
logarithmic transformations to both interacting variables. All interaction terms were 
included in the final model in a separate block so that main effects could be examined 
prior to the addition of interaction terms. Simple slopes were probed at the 1 SD below 
the mean, at the mean, and 1 SD above the mean for continuous variables (referred to as 
                                                 
3 Because gender was a hypothesized moderator, it might be of interest to test whether there was weak 
evidence for a similar gender-by-depression or gender-by-aggression/antisociality interaction in predicting 
alcohol use in AFDP (e.g., marginally significant interaction term, similar simple slopes). Neither of these 
interactions was marginally significant (p < 0.10), and the simple slopes of these non-significant interaction 
terms were also dissimilar to the patterns seen in CDP. For example, higher levels of depression predicted 
lower levels of alcohol use for girls in AFDP. The only exception was that the standardized regression 
coefficient of aggression/antisociality on alcohol use was higher for boys than for girls, although the 
interaction was not statistically significant.   
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low, mean, and high levels, respectively). Standardized regression coefficients are 
reported to describe the simple slopes of significant interaction effects.  Results from the 
final CDP model are organized by outcome. See Table 7 and Figure 4. 
T1 conscientiousness. 5-HT polygenic risk did not predict T1 conscientiousness4. 
Females had higher conscientiousness than males.  
 T2 aggressive/antisocial behaviors. 5-HT polygenic risk and conscientiousness 
did not have main effects on T2 aggressive/antisocial behaviors. Adolescents with higher 
levels of T1 aggressive/antisocial behaviors had higher levels of T2 aggressive/antisocial 
behaviors.  
 The significant polygenic risk-by-SES and conscientiousness-by-SES interactions 
were entered in a second block. The pattern of the 5-HT polygenic risk interaction was 
such that higher levels of 5-HT polygenic risk predicted higher levels of T2 
aggressive/antisocial behaviors at low levels of SES (β = 0.16, p = 0.01), but predicted 
lower levels of T2 aggressive/antisocial behaviors at high levels of SES (β = -0.19, p = 
0.01). 5-HT polygenic risk did not predict T2 aggressive/antisocial behaviors at mean 
levels of SES (β = -0.03, p = 0.67). The pattern of the conscientiousness interaction was 
such that lower levels of conscientiousness significantly predicted higher levels of T2 
aggressive/antisocial behaviors at low levels of SES (β = -0.16, p = 0.01), marginally 
                                                 
4 The item “How forgetful do you think you are?” in the Conscientiousness scale might be the least 
reflective of effortful control of all items in the scale. Thus, conscientiousness was recomputed by dropping 
this item. Dropping this item reduced Cronbach’s alpha from 0.64 to 0.60. In addition, preliminary zero-
order correlations suggested that polygenic risk, aggression/antisociality, depression, and alcohol use all 
related less strongly with the new conscientiousness composite score. Thus, the original conscientiousness 
scale was retained for all analyses.  
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significantly at mean levels of SES (β = -0.08, p = 0.08), but did not predict at high levels 
of SES (β = 0.02, p = 0.70). See Figures 7 and 8. 
 T2 depressive symptoms. 5-HT polygenic risk did not have a main effect on T2 
depressive symptoms. Lower levels of T1 conscientiousness predicted higher levels of T2 
depressive symptoms. Females and adolescents with higher levels of T1 depressive 
symptoms had higher levels of T2 depressive symptoms. 
 The significant polygenic risk-by-SES and conscientiousness-by-SES interactions 
were entered in a second block. The pattern of the 5-HT polygenic risk interaction was 
such that higher levels of polygenic risk predicted higher levels of T2 depressive 
symptoms at low levels of SES (β = 0.17, p = 0.01), but marginally significantly 
predicted lower levels of T2 depressive symptoms at high levels of SES (β = -0.13, p = 
0.07). 5-HT polygenic risk did not predict T2 depressive symptoms at mean levels of SES 
(β = 0.06, p = 0.29). The pattern of the conscientiousness interaction was such that lower 
levels of conscientiousness predicted higher levels of T2 depressive symptoms at low (β 
= -0.30, p < 0.001) and mean levels of SES (β = -0.16, p = 0.003), but not at high levels 
of SES (β = 0.004, p = 0.96). See Figures 9 and 10.  
 T3 alcohol use. Lower levels of 5-HT polygenic risk (i.e., higher levels of 
serotonin functioning) marginally significantly predicted higher levels of T3 alcohol use. 
Conscientiousness did not predict T3 alcohol use. T2 aggressive/antisocial behaviors and 
depressive symptoms did not have main effects on T3 alcohol use. Females and 
adolescents with higher levels of SES, parental alcohol problems, and T2 alcohol use had 
higher levels of T3 alcohol use.  
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 The significant gender-by-T2 aggressive/antisocial behaviors and gender-by-T2 
depressive symptoms interactions were entered in a second block. The pattern of the 
former interaction was such that higher levels of T2 aggressive/antisocial behaviors only 
prospectively predicted higher levels of T3 alcohol use for boys (β = 0.34, p = 0.01, OR = 
1.30), but not for girls (β = -0.06, p = 0.60, OR = 0.96). The pattern of the latter 
interaction was such that higher levels of T2 depressive symptoms marginally 
significantly predicted higher levels of T3 alcohol use for girls (β = 0.15, p = 0.06, OR = 
1.10), but did not predict for boys (β = -0.23, p = 0.12, OR = 0.90). See Figures 11 and 
12. 
Models omitting autoregressive paths. The 5-HT polygenic risk score did not 
predict any outcomes differently after removing autoregressive paths.  
  Moderated mediation. Because the a and b paths of several of the mediational 
chains in the final CDP model were moderated by different variables, simple slope 
analyses tested the a and b paths at every possible combination of the relevant 
moderators. For instance, 5-HT polygenic risk predicted T2 aggressive/antisocial 
behaviors, but only at certain levels of SES, and T2 aggressive/antisocial behaviors 
subsequently predicted T3 alcohol use, but only for males. To examine at which 
combinations of SES and gender this mediational chain was significant, a polygenic risk-
by-gender interaction term was included in predicting T2 aggressive/antisocial behaviors 
and an aggressive/antisocial behavior-by-SES interaction term was included in predicting 
T3 alcohol use. By assigning males a code of ‘0’ and centering SES at 1 SD below the 
mean, both main effect paths in this mediational chain would now refer to the effect for 
males with low SES. This procedure was completed for all possible mediational effects 
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and combinations of moderators by re-centering each of the continuous moderating 
variables at 1 SD above and below the mean and at the mean, and by re-centering each of 
the dichotomous moderators such that different categories were equal to zero (see Table 
9). 
 These analyses showed that higher levels of 5-HT polygenic risk indirectly 
predicted higher levels of T3 alcohol use through greater T2 aggressive/antisocial 
behaviors, but only for males with low levels of SES. However, lower levels of 5-HT 
polygenic risk indirectly predicted higher levels of T3 alcohol use through greater T2 
aggressive/antisocial behaviors for males with high levels of SES. In addition, lower 
levels of conscientiousness indirectly predicted higher levels of T3 alcohol use through 
greater T2 aggressive/antisocial behaviors, but only for males with low levels of SES.   
Comparing Results from AFDP and CDP 
 Because of the complex patterns of moderation found in both studies, it was 
informative to organize the main results of interest in a side-by-side comparison format. 
See Table 10. 
Discussion 
 The purpose of the current study was to test an integrated, developmental model 
to better understand the relation between serotonergic functioning and alcohol use. This 
study tested the hypothesis that 5-HT polygenic risk (i.e., reflecting serotonin 
functioning) would create a vulnerability for poor effortful control, which would, in turn, 
predict the divergent outcomes of depressive symptoms and aggressive/antisocial 
behaviors. The hypothesis further posited that depressive symptoms and 
aggressive/antisocial behaviors would subsequently predict later alcohol use, but that 
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direct effects of 5-HT polygenic risk and/or effortful control on alcohol use might still 
remain. This hypothesis was tested in two independent longitudinal samples and, 
therefore, the first sections will focus on replicated findings across samples. 
5-HT Polygenic Risk and Effortful Control/Conscientiousness 
 The first major finding was that the polygenic risk score created to index 
serotonergic functioning (i.e., 5-HIAA in the cerebrospinal fluid) did not predict effortful 
control in AFDP or conscientiousness in CDP. Therefore, the current data do not support 
the hypothesis that adolescents with lower levels of serotonin functioning have a 
vulnerability for deficits in effortful and trait like components of self- regulation. Further, 
the data do not support the notion that self-regulation is the mechanism through which 
serotonin functioning creates risk for multiple types of psychopathology. Of course, one 
reason for this finding might be due to methodological limitations of the 5-HT polygenic 
risk scores. Indeed, only 23 SNPs were included in both scores, and many more genetic 
variants are involved in the complex process of serotonin functioning.  
 However, this concern might be mitigated by the other evidence of predictive 
validity demonstrated by the 23-SNP 5-HT polygenic risk score. Consistent with the 
previous literature, individuals with greater scores on 5-HT polygenic risk (reflecting 
lower levels of serotonin functioning) had greater depressive symptoms, 
aggressive/antisocial behaviors, and alcohol use across samples (albeit for certain 
subgroups in CDP). This suggests that the 5-HT polygenic risk scores might capture the 
intended construct, and that the limitations of the scores likely do not account for the lack 
of association between 5-HT polygenic risk and self-regulation (see Carver et al., 2008; 
LeMarquand et al., 1994a, 1994b; Van Goozen et al., 2007).  
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Alternatively, another reason that the 5-HT polygenic risk score did not predict 
effortful control or conscientiousness could be because of inadequate measurement of 
these latter two constructs. However, similar to the 5-HT polygenic risk score, these self-
regulatory constructs demonstrated predictive validity. As expected, effortful control and 
conscientiousness were related to adolescents’ depressive symptoms and 
aggression/antisociality in both samples (albeit for certain subgroups in CDP). Effortful 
control was also associated with adolescents’ alcohol use in AFDP.   
Moreover, the measurement of effortful control in AFDP was particularly strong, 
which further decreases the likelihood that inadequate measurement was the reason that 
polygenic risk effects were not detected. Effortful control reflected what was common 
across multiple observers of adolescents’ effortful control because mother-, father-, and 
adolescent-reported effortful control were used to create the measure. Moreover, the 
Early Adolescent Temperament Questionnaire, from which the effortful control scale was 
derived, has been shown to be reliable and valid based on previous work (Capaldi & 
Rothbart, 1992). Conscientiousness in the CDP was somewhat less robustly measured 
because only adolescents self-reported on the measure and it contained only 5 items. 
However, the fact that this measure of self-regulation produced similar results to the 
stronger measure of effortful control suggests that inadequate measurement of self-
regulation is likely not the reason that polygenic risk was not related to effortful control 
or conscientiousness.  
Finally, perhaps no associations were found between 5-HT polygenic risk and 
self-regulatory constructs because the effect of 5-HT polygenic risk is actually non-linear. 
Indeed, the current study did not propose to test non-linear effects of 5-HT polygenic 
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risk. This possibility is buttressed by our findings that, in some cases, CDP adolescents 
with lower levels of 5-HT polygenic risk had higher levels of depression, 
aggression/antisociality, and alcohol use (but, see later sections for more details about 
these findings). Thus, perhaps individuals with both higher levels and lower levels of 5-
HT polygenic risk have the lowest levels of effortful control, whereas individuals with 
average levels of 5-HT polygenic risk have the highest levels of effortful control. 
However, post-hoc analyses that included a quadratic 5-HT polygenic risk term in the 
final models showed that the quadratic effect of 5-HT polygenic risk was not significant 
for any of the outcomes.  
Because the 5-HT polygenic risk scores demonstrated predictive validity, it is 
worth elaborating upon the strengths of the scores and the SNPs that were included. First, 
the promising results found using the 5-HT polygenic risk scores suggest that the use of 
genome-wide association studies (GWAS) to create polygenic risk scores is a valuable 
approach. This approach might be especially useful in the service of better understanding 
the role of genetic risk in developmental models of psychopathology. Second, it is 
noteworthy that we were able to directly infer the functional significance of the 5-HT 
polygenic risk score because we selected SNPs that were associated with 5-HIAA 
concentrations in the cerebrospinal fluid in a previous GWAS. This is an improvement 
over some previous studies that have created polygenic risk scores to index broad 
psychological disorders. Indeed, this broader method does not as easily allow researchers 
to form specific hypotheses about the biological mechanisms underlying polygenic risk 
scores because genetic variants belonging to different biological pathways are often 
combined into a single score.  
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 It is also potentially interesting to note that some of the SNPs included in the 
score might play a functional role in gene expression and/or have been associated with 
substance-related phenotypes in the literature. Notably, rs1799971, located in the 
OPRM1 gene, has been extensively studied and was recently shown to predict substance 
dependence in a meta-analysis of 28,000 European American adults (Schwantes-An et 
al., 2015). This variant has also been shown to functionally influence mu-opioid receptor 
expression levels, binding affinity, and signaling (Befort, Filliol, Decaillot, Gaveriaux-
Ruff, Hoehe, & Kieffer, 2001; Beyer, Koch, Schröder, Schulz, & Hollt, 2004; Wang, 
Huang, Ung, Blendy, & Liu-Chen, 2012). Similarly, rs760288, located in NRXN3, 
distinguished between individuals who were dependent on illegal substances from 
controls across two different samples (Liu, 2005). Interestingly, this SNP forms a 
haplotype block with rs8019381, which has been posited to influence alternative splicing 
in exon 23 of this gene (Sasabe & Ishiura, 2010). These SNPs might influence 
serotonergic functioning through their aforementioned functional effects or through 
different mechanisms entirely. It is difficult to hypothesize the mechanism of action by 
which these SNPs influence serotonergic functioning based on current information.  
Several other SNPs in the polygenic risk score have also been associated with 
substance use phenotypes, although little has currently been published on their potential 
functional effects. These include rs6494212 (CHRNA7), rs135757 (CSNK1E), 
rs2236256 (IPFCEF1), and rs2272381 (OPRM1; Chen et al., 2011; Levran et al., 2008; 
Saccone et al., 2010; Smelson et al., 2012). Note that most of these results were derived 
from candidate gene studies with relatively small sample sizes, which suffer from 
limitations such as difficulties with replication (Plomin, DeFries, Knopik, & Neiderhiser, 
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2016). However, it is possible that these SNPs are related to substance use phenotypes 
through their effects on serotonergic functioning.  
5-HT Polygenic Risk and Adolescents’ Problem Behaviors 
 As noted earlier, adolescents with higher 5-HT polygenic risk scores (i.e., lower 
serotonin functioning) had greater levels of aggressive/antisocial behaviors and 
depressive symptoms in both AFDP and CDP. However, in CDP, the effects of 5-HT 
polygenic risk on greater depression and aggression/antisociality only held for 
adolescents with low levels of SES. Two points are important to note. First, the fact that 
serotonin functioning as indexed by a polygenic risk score predicted adolescents’ 
symptomatology (for certain subgroups) across two samples is consistent with multiple 
previous studies. Specifically, other work has found that serotonin functioning as indexed 
by 5-HIAA in the cerebrospinal fluid, tryptophan depletion/enhancement, and blunted 
hormonal responses to drug challenges (among others) related to children’s and adults’ 
aggression, delinquency, antisociality, and depressive symptoms and disorder (Booij & 
Van der Does, 2007; Clarke et al., 1999; Dencker, Malm, Roos, & Werdinius, 2006; 
Flory et al., 1998; Halperin et al., 2006; Kruesi et al., 1990, 1992; Lidberg et al., 1985; 
Limson et al., 1991; Traskman-Bendz et al., 1984). These results were such that lower 
levels of serotonin functioning were associated with greater problems. Taken together, 
this presents strong evidence that individuals with lower levels of serotonergic 
functioning are more prone towards developing aggressive/antisocial behaviors and 
depressive symptoms in childhood and adulthood. Note that in the CDP we also found 
the opposite relation for adolescents with high levels of SES, wherein lower levels of 
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polygenic risk predicted greater levels of aggression/antisociality. Because this was not 
replicated in AFDP, this finding will be discussed further in a later section. 
 Second, it is important to understand why 5-HT polygenic risk was moderated by 
SES in predicting behavioral problems, but only in the CDP.  It is possible that the 
smaller sample size of AFDP (N = 254) compared to CDP (N = 348) resulted in lowered 
power to detect this moderation effect in AFDP. Alternatively, perhaps polygenic risk 
only had main effects in AFDP because AFDP is a high-risk sample in which participants 
likely have greater genetic vulnerabilities for problem behaviors compared to CDP 
participants who represent a general community sample. Finally, it is possible that 
differences in SES across samples account for findings. Although the SES variables 
available in each sample were not identical, comparing the SES across samples suggests 
that CDP participants more highly represent the upper levels of education than do AFDP 
participants. For example, 46.8% of CDP participants’ parents obtained at least 16-17 
years of education or higher, which roughly corresponds to obtaining at least a Bachelor’s 
degree or higher. Fewer AFDP participants’ parents (35.1%) obtained a Bachelor’s 
degree or higher. Similarly, 19% of CDP participants’ parents obtained 18+ years of 
education, which roughly corresponds to some graduate or professional schooling or the 
completion of a graduate degree. Again, a smaller percentage (12%) of AFDP 
participants’ parents obtained some graduate or professional schooling and/or completed 
a graduate degree. Comparing SES levels at the lower end of the distribution similarly 
suggests that AFDP participants might be more representative of lower levels of SES 
than CDP. For example, 6.5% of AFDP participants’ parents did not graduate from high 
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school (some in this group obtained a GED), whereas fewer (3.5%) CDP participants’ 
parents obtained 10-11 years of schooling or less.  
Thus, perhaps the effect of serotonin functioning on depressive and 
aggressive/antisocial symptomatology is truly stronger or only present under conditions 
of low SES (as was found in CDP), and perhaps this was captured as a main effect in 
AFDP because low SES participants were more highly represented in this sample. 
Relatedly, perhaps this effect was only conditional on SES in CDP because CDP 
participants had greater variability at the upper end of the distribution of SES, facilitating 
the detection of differential effects at high levels of SES.    
If differences in SES variability account for the differential moderation by SES 
across studies, we might expect to see weak polygenic risk-by-SES interaction effects in 
predicting AFDP adolescents’ aggression/antisociality and/or depression that perhaps did 
not survive FDR corrections in original analyses. Thus, to further probe and understand 
this polygenic risk-by-SES effect, post-hoc analyses tested whether a polygenic-risk-by-
SES interaction predicted AFDP adolescents’ aggression/antisociality or depressive 
symptoms. Interestingly, the polygenic-risk-by-SES interaction marginally significantly 
predicted aggression/antisociality (β = -0.08, p = 0.099). The interaction was such that 
higher levels of 5-HT polygenic risk (lower serotonin functioning) significantly predicted 
greater aggression/antisociality at low (β = 0.20, p = 0.01) and mean (β = 0.12, p = 0.02) 
levels of SES, but not at high levels of SES (β = 0.03, p = 0.59). Perhaps this interaction 
would have survived corrections for multiple testing if AFDP had a larger sample size or 
more variability in the upper range of SES.  
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This finding supports the possibility that the effect of 5-HT polygenic risk on 
greater aggression/antisociality is amplified at low SES. Although this post-hoc analysis 
does not support the possibility that 5-HT polygenic risk effects are reversed at high 
levels of SES (as was found in CDP), it does not contradict it either. This is because we 
might not expect to obtain similar effects at high SES in AFDP and CDP given that 
AFDP has less variability in the upper range of SES than CDP. Finally, note that the 
same trend towards an interaction was not found for depressive symptoms in AFDP. 
However, it is possible that corresponding effects were not found for depression because 
AFDP had lower SES variability and power, especially in light of the fact that the 
polygenic risk-by-SES interaction in predicting aggression/antisociality was clearly 
weaker in AFDP compared to CDP.   
 In sum, there are several reasons to believe that this SES moderation is not 
spurious, despite the fact that we only found the effect in one sample. The findings that 5-
HT polygenic risk only predicted aggression/antisociality and depression for adolescents 
with low levels of SES in the CDP are consistent with previous research suggesting that 
genetic risk variants more strongly predicted adolescents’ greater externalizing- and 
internalizing-related outcomes under conditions of low SES or high environmental 
adversity (Laucht et al., 2009; Nobile et al., 2007, 2010; Sweitzer et al., 2013). This 
pattern is consistent with the dual-risk or diathesis-stress model, which suggests that the 
combination of adverse environmental conditions and individual risk factors constitutes 
the greatest risk for the development of problems (Monroe & Simons, 1991). Indeed, a 
large body of work has established that low SES is associated with multiple negative 
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health and socioemotional outcomes, in part because it decreases access to resources and 
is associated with higher levels of stress (Bradley & Corwyn, 2002).  
Interestingly, this polygenic risk-by-SES interaction could also be due to the fact 
that one’s SES can influence the expression of genetic material through DNA 
methylation, histone modification, or other processes (i.e., epigenetic influences). For 
example, one previous study showed that lower levels of SES were associated with 
genome-wide hypomethylation in adults after controlling for their gender, age, and other 
lifestyle factors related to SES such as health and housing (McGinnis et al., 2012). Lower 
levels of SES also predicted genome-wide changes in methylation for adolescents who 
carried the s allele of the 5-HTTLPR polymorphism, after controlling for age and gender 
(Beach, Brody, Lei, Kim, & Cui, 2014). Thus, it is possible that low SES conditions, 
and/or some correlate of low SES, altered the epigenomic state of one or several genes in 
the 5-HT polygenic risk score (i.e., altered gene expression), and this could explain why 
polygenic risk effects were conditional on SES.  
The fact that high SES adolescents with lower levels of 5-HT polygenic risk (i.e., 
higher serotonin functioning) had greater aggression/antisociality is more difficult to 
interpret due to a lack corresponding effects in AFDP. That is, adolescents with lower 
levels of polygenic risk (i.e., higher serotonin functioning) did not have greater levels of 
any symptom measure in AFDP. It is important to briefly note that other studies in the 
literature have found that higher levels of serotonin functioning were associated with 
greater aggression and hostility in children, adolescents, and adults (i.e., Castellanos et 
al., 1994; Pine et al., 1997; Halperin et al., 1994; Hughes et al., 1996).  
      
 72  
Despite evidence for the opposite direction of effect in the current study and 
previous studies, a recent meta-analysis of 175 independent samples that included most 
of the aforementioned studies (i.e., Castellanos et al., 1994; Pine et al., 1997; Halperin et 
al., 1994) found an overall small effect of serotonin functioning on aggression-related 
phenotypes, such that lower levels of serotonin functioning predicted greater levels of 
aggression (Duke, Begue, Bell, & Eisenlohr-Moul, 2013). These authors also explored 
potential moderating variables that might account for differences in results across the 175 
studies (e.g., why some studies found positive, and others negative, correlations). They 
found that the differences in outcomes were not explained by moderators such as 
experimental design, sample size, effect size, assessment instruments and methods used, 
presence of control conditions, age, gender, race/ethnicity, and other psychopathology. 
However, the use of self- vs. other-reported measures did moderate study outcome 
variability. The pattern was such that other-reported measures of greater aggression 
tended to correlate positively with higher serotonin functioning whereas self-reported 
measures of greater aggression tended to correlate positively with lower serotonin 
functioning. However, this moderator does not explain our reversed findings because we 
only used self-reported, and not other-reported, measures of aggression/antisociality. 
Although this meta-analysis did not assess SES as a moderator, there was no systematic 
evidence that the samples from studies that found the opposite direction of effect had 
particularly high SES.  
Taken together, the previous literature and the current findings suggest the 
possibility that the observed reversed relation (i.e., higher serotonin functioning 
associated with greater aggression) could be accounted for by some other untested 
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moderator, or could likely be spurious. The most reliable information gleaned from the 
current study is that higher scores on the 5-HT polygenic risk score (which reflects lower 
levels of serotonin functioning) represents risk for adolescents’ depression and 
aggression/antisociality, and that this association might be amplified under adverse 
economic conditions. 
 In summary, the current findings suggest that adolescents with lower levels of 
serotonin functioning as indexed by this 5-HT polygenic risk score have higher levels of 
depressive and aggressive/antisocial behaviors (perhaps more strongly under low SES 
conditions). However, this 5-HT polygenic risk score does not appear to be associated 
with self-regulatory constructs. Thus, one interesting avenue of future research would be 
to better understand whether there is a common underlying trait, physiological marker, or 
other biological phenotype intermediate between serotonergic functioning and these 
divergent forms of problem behavior in adolescence. Moreover, results suggest that 
serotonin functioning could be a valuable candidate for future research on transdiagnostic 
risk factors.  
Aggression/Antisociality and Alcohol Use 
 In both samples, greater levels of aggressive/antisocial behaviors prospectively 
predicted greater levels of later alcohol use. However, this effect only held for boys in the 
CDP sample. The CDP gender differences did not appear to be related to differences in 
variability for boys versus girls. Indeed, Levene’s test of the homogeneity of variances 
suggested that the variances of aggressive/antisocial behaviors (F(1) = 0.02, p = 0.88) and 
alcohol use (F(1) = 1.78, p = 0.18) did not differ for boys and girls. This finding mirrors 
that of other studies, which showed that antisociality, conduct disorder, novelty seeking, 
      
 74  
and behavioral undercontrol (i.e., externalizing-related traits and outcomes) predicted 
alcohol phenotypes more strongly for males than for females (e.g., Caspi, Moffit, 
Newman, & Silva, 1996; Hussong, Curran, & Chassin, 1998; Kendler, Edwards, & 
Gardner, 2015). The inconsistency between CDP and AFDP with regards to this finding 
could be due to several reasons.  
First, as stated previously, perhaps AFDP had lower power to detect gender 
moderation than CDP due to a smaller sample size. Second, a recent review of the 
literature showed that women’s drinking rates began to catch up with men’s drinking 
rates in the time spanning 1989-2009, possibly due to differences in the societal structure 
of gender roles or social norms (Keyes, Li, and Hasin, 2011). Because the CDP 
participants self-reported alcohol use over a decade earlier (1997-1998) than AFDP 
participants (2012-2013), perhaps aggression/antisociality only predicted alcohol use for 
boys in the CDP because there were greater negative social sanctions against drinking for 
females than males during CDP data collection. If this is true, alcohol use could have 
been a less likely consequence or correlate of females’ externalizing problems in the 
CDP, but not in AFDP. Third, this finding could be due to the fact that AFDP is a high-
risk sample, in which over half of all participants had a parent with an SUD, whereas the 
CDP was a community sample. Moreover, in the subsample of adolescents we selected 
from AFDP, there happened to be a significantly greater percentage of girls (55.4%) than 
boys (44.6%) whose parents had an SUD (χ2(1) = 5.68, p = 0.02; also see Table 2). 
Perhaps the greater percentage of females with a high genetic and familial loading for 
substance use in the AFDP sample resulted in aggression/antisociality being equally 
predictive of alcohol use in boys and girls.  
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The Indirect Effect of 5-HT Polygenic Risk on Alcohol Use 
 In both AFDP and CDP, 5-HT polygenic risk prospectively and indirectly 
predicted later alcohol use through adolescents’ aggression/antisociality, such that greater 
levels of 5-HT polygenic risk (i.e., lower levels of serotonin functioning) predicted 
greater aggression/antisociality, which predicted greater alcohol use. However, this path 
was only significant for boys with low SES in the CDP sample (i.e., moderated 
mediation).5 This finding is a novel contribution to the literature. Although studies have 
found associations between indices of serotonin functioning and aggression, antisociality, 
and alcohol use and disorder (e.g., Halperin et al., 2006; Kruesi et al., 1990, 1992; 
LeMarquand et al., 1994a, 1994b Lidberg et al., 1985; Limson et al., 1991), this is the 
first study to our knowledge to show that aggression/antisociality might be one 
mechanism underlying the relation between serotonergic functioning and alcohol 
consumption.  
Perhaps individuals with lower levels of serotonin functioning have a 
predisposition towards aggressive, delinquent, and/or deviant behaviors, which prompts 
affiliation with deviant peer groups and, subsequently, increases alcohol use (e.g., Sher, 
1991). This might be especially true for individuals who are already at high risk for these 
behaviors, such as boys with low SES (e.g., Bradley & Corwyn, 2002; Else-Quest et al., 
2006). Findings are also consistent with the possibility that serotonergic functioning 
manifests as different behavioral phenotypes across development (i.e., heterotypic 
                                                 
5 In the CDP, lower polygenic risk also indirectly predicted greater alcohol use through greater 
aggression/antisociality for boys with high SES. Because the a path in the aforementioned mediated effect 
could be spurious due to a lack of replication (i.e., lower polygenic risk predicting greater 
aggression/antisociality at high SES), this mediated effect will not be elaborated upon further. 
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continuity). To illustrate, since we did not find that serotonergic functioning predicted 
effortful control, perhaps it predicts some facet of behavioral disinhibition. Indeed, 
research suggests that behavioral disinhibition presents a generalized vulnerability for 
developing externalizing problems (Young et al., 2009). If this were true, it is possible 
that a greater vulnerability for behavioral disinhibition is primarily expressed as 
aggression and delinquency in earlier adolescence and later expressed as greater alcohol 
use due to increases in autonomy, access to substances and peer alcohol use. 
Effortful Control/Conscientiousness and Adolescents’ Problem Behaviors 
 Similarly, in both AFDP and CDP, effortful control/conscientiousness 
prospectively predicted aggressive/antisocial behaviors and depressive symptoms, such 
that lower levels of effortful control/conscientiousness predicted greater levels of 
problem behaviors. However, in CDP the effect on aggression/antisociality only held for 
adolescents with low levels of SES and the effect on depression only held for adolescents 
with low and mean levels of SES. The fact that SES was found to moderate the effects of 
two virtually unrelated, independent risk factors (i.e., 5-HT polygenic risk and 
conscientiousness; see Tables 2 and 3) further suggests that the SES moderation found in 
CDP was not spurious. It also indicates that CDP participants’ SES is an important 
environmental factor that protects against or exacerbates the effects of individual 
differences in predicting problem behaviors. Note that many of the same reasons that SES 
moderated the effects of 5-HT polygenic risk in the CDP and not in AFDP likely apply to 
these findings (i.e., SES variability differences, power differences, high-risk vs. 
community samples). Similar to the polygenic risk-by-SES interaction, perhaps we might 
expect to see weak effortful control-by-SES interactions in predicting problem behaviors 
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in AFDP that did not survive original FDR corrections. Although post-hoc analyses 
showed that effortful control did not significantly or marginally significantly interact with 
SES to predict problem behaviors in the AFDP sample, the lack of such an interaction in 
AFDP could still be due to lowered power or SES variability.  
Taken together, findings suggest that impairments in self-regulatory abilities 
prospectively predict greater change in adolescents’ aggression/antisociality and 
depression. These results are consistent with multiple previous studies (e.g., Loukas & 
Robinson, 2004; Loukas & Roalson, 2006; Muris et al., 2008; Verstraeten et al., 2009; 
Wang et al., 2015a). Although not replicated in AFDP, results also provide preliminary 
evidence that deficient self-regulation is especially detrimental for economically 
disadvantaged adolescents. Perhaps a lack of self-regulation did not predict problem 
behaviors for adolescents from higher SES families because these adolescents have 
greater access to resources from parents, neighborhoods, and schools (Bradley & Corwyn 
2002). This greater access might help these adolescents develop compensatory strategies 
to deal with their poor regulatory abilities and this could curb the development of 
problem behaviors in this subgroup. In contrast, without these resources, adolescents with 
low levels of SES might not learn new ways of dealing with their self-regulatory deficits 
and might manifest problem behaviors as a result.  
Other studies have similarly found interactions between self-regulatory constructs 
and other aspects of the environment in predicting problem behaviors. Specifically, 
adolescents with both lower levels of self-regulation (i.e., conscientiousness or effortful 
control) and greater coercive parenting, lower parental emotional expressivity, negative 
parental control, or lower maternal guidance had the greatest externalizing problems or 
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depressive symptoms (Prinzie et al., 2003; Kiff, Lengua, & Bush, 2011; Van Leeuwen, 
Mervielde, Braet, & Bosmans, 2004; Wang, Eisenberg, Valiente, & Spinrad, 2015b). 
These interaction effects could be due to the cumulative risk of regulatory deficits and 
poor parenting. These interactions could also arise if adolescents with low self-regulatory 
abilities have trouble inhibiting problematic behaviors or emotions that occur in response, 
or as a reaction to, harsh or poor parenting practices. Given that distress among parents 
with low SES might contribute to their over-use of negative control, low warmth, and low 
monitoring (McLoyd, 1990), perhaps the moderating role of SES operates indirectly 
through these parenting behaviors 
The Indirect Effect of Effortful Control/Conscientiousness on Alcohol Use  
Deficits in self-regulation (i.e., effortful control and conscientiousness) also 
indirectly predicted greater levels of alcohol use through aggressive/antisocial behaviors. 
However, this mediated effect only held for boys with low SES in the CDP. Interestingly, 
in AFDP, the effect of effortful control on alcohol use appeared to be entirely mediated 
through antisociality/aggression because there was no longer a direct effect of effortful 
control on alcohol use after accounting for this mediator. Multiple previous studies have 
linked effortful control/self-regulation with aggression/antisociality and substance use 
phenotypes separately (Cheetham et al., 2010; Creemers et al., 2010; Loukas & Roalson, 
2006; Loukas & Robinson, 2004; Wang et al., 2015a; Willem et al., 2011). This study is 
the first to our knowledge to link these constructs together in a developmental and 
longitudinal framework. Specifically, it appears that deficits in self-regulation are related 
to changes in alcohol use over time because this trait predisposes adolescents to an earlier 
risk factor for alcohol use, namely, aggression/antisociality. Adolescents with high levels 
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of aggression/antisociality might drink more alcohol because they affiliate with deviant 
peers, or as a way to dampen negative affectivity associated with aggression (e.g., anger). 
It could also be that deficits in effortful control manifest as different correlated 
phenotypes at different points in development (i.e., aggression/antisociality and alcohol 
use).  
Results also point to the possibility that deficits in effortful control represent 
another pathway to alcohol problems, in addition to the more common deviance 
proneness and stress dampening pathways (see Sher, 1991). That is, in addition to one 
pathway characterized by sensation seeking, reward sensitivity, and impulsivity (i.e., 
deviance proneness), and a second pathway characterized by negative affectivity and self-
medication (stress dampening), a third pathway might be characterized by a more global, 
top-down inability to regulate behaviors, thoughts and feelings. On the other hand, it is 
likely that effortful control is implicated in both the deviance proneness and stress 
dampening pathways because each of these pathways also involve difficulties in 
regulating behaviors, thoughts, or feelings. Thus, effortful control might simply 
contribute to deviance proneness and/or stress dampening processes.  
Finally, results suggest that self-regulation is an important transdiagnostic risk 
factor because it predicts multiple types of problem behaviors, including 
aggression/antisociality, depression, and alcohol use (indirectly). Prevention and 
intervention efforts to increase effortful control/conscientiousness might be helpful and 
effective in reducing many kinds of psychopathological problems in adolescence.  
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Study Specific Findings and Cross-Study Comparisons 
 The link between adolescents’ depression and alcohol use exhibited some 
consistency across studies. Namely, there was replication at the zero-order correlation 
level, wherein higher levels of depression correlated positively with higher levels of 
alcohol use. However, after adding all of the covariates and predictors to the models, 
these paths were no longer the same across the two studies. In CDP, there was no main 
effect of depression on alcohol use. However, depression and gender interacted to predict 
alcohol use such that higher levels of depressive symptoms marginally significantly 
predicted greater levels of alcohol use for girls but not for boys. In AFDP, there was also 
no main effect of depression on alcohol use. However, depression interacted with both 
SES and ancestry to predict alcohol use, such that higher levels of depressive symptoms 
predicted lower levels of alcohol use for adolescents with low and mean levels of SES 
and ancestry (i.e., greater Mexican/Mexican-American ancestry), but not for adolescents 
with high levels of SES or ancestry. 6  Note that removing aggression/antisociality from 
the model, which was highly correlated with depressive symptoms (r = 0.68), did not 
change the negative direction of the effect of depression on alcohol use in AFDP. This 
suggests that some combination of multiple predictors and covariates, rather than only 
aggression/antisociality, accounts for this reversal effect in AFDP. 
                                                 
6 Because of this moderation effect, depression also served as a mediator in the link between effortful 
control and alcohol use and between polygenic risk and alcohol use in AFDP. Specifically, greater effortful 
control and polygenic risk indirectly predicted lower alcohol use through greater depressive symptoms for 
adolescents low and mean levels of SES and/or ancestry. These significant moderated mediation effects are 
not elaborated on further because the b path in this mediational chain (i.e., depression to alcohol use) might 
be spurious and was not replicated. 
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Our findings mirror the previous literature investigating the link between 
adolescents’ depression and later alcohol use, which has also been equivocal. For 
example, some previous research showed that depressive symptoms in adolescence raised 
the risk for later alcohol use, abuse, and substance use disorder in adolescence even after 
controlling for co-occurring externalizing problems in most cases (e.g., Conway et al., 
2016; Henry et al., 1993; Hussong & Chassin, 1994; King, Iacono, & McGue, 2004; 
Sung et al., 2004). However, other studies that controlled for externalizing risk found that 
adolescents’ depression and internalizing symptoms did not predict later heavy drinking 
in adolescence or alcohol use disorders in young adulthood (Hussong, Curran, & Chassin, 
1998; Pardini, Raskin White, & Stouthamer-Loeber, 2007). Finally, studies have also 
found that internalizing problems, particularly in the absence of externalizing problems, 
protected against substance use (i.e., Colder et al., 2013; Kaplow, Curran, Angold, & 
Costello, 2001). Taken together, this suggests that the unique effect of adolescents’ 
depression on alcohol use after controlling for relevant covariates and other robust 
predictors (i.e., aggression/antisociality) is complex not easily interpretable. Several 
researchers have suggested that the effect of adolescents’ internalizing symptoms on 
alcohol use might vary based on other important moderating variables not tested in the 
current study (e.g., impulsivity, coping styles, externalizing problems; Hussong, Curran, 
& Chassin, 1998; Pardini et al., 2007) or might not be as strong or relevant of a predictor 
as is adulthood depression on alcohol use outcomes (Hussong, Curran, & Chassin, 1998).  
Although beyond the scope of the current study, these possibilities deserve further study. 
 Finally, in AFDP, 5-HT polygenic risk had a significant direct effect on alcohol 
use after accounting for earlier symptoms and effortful control, such that individuals with 
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higher 5-HT polygenic risk scores had greater alcohol use. In contrast, individuals with 
lower 5-HT polygenic risk scores had marginally significantly greater levels of alcohol 
use in CDP after controlling for similar variables. AFDP’s findings are more consistent 
with the previous literature on this topic. Indeed, multiple studies found that serotonergic 
functioning as measured by 5-HIAA in the cerebrospinal fluid, drug challenge, and 
platelet serotonin uptake was lowered in adults with alcohol use disorders and in children 
and adults with family histories of alcohol disorder vs. controls (Balldin et al., 1994; 
Ballenger et al., 1979; Banki, 1981; Borg et al., 1985; Ernouf et al., 1993; Farren et al., 
1995; Füs-Aime et al., 1996; Lee & Meltzer, 1991; Rausch et al., 1991).  
The conflicting direct effects found in AFDP vs. CDP are difficult to understand, 
especially in light of the fact that the indirect effect of polygenic risk on alcohol use 
through aggression/antisociality was in the same direction in both samples. However, it is 
possible that the expected direction of effect (wherein lower levels of serotonin 
functioning are associated with greater levels of alcohol use) only holds for certain 
subgroups in CDP, similar to its effects on depression and aggression/antisociality in this 
sample. Perhaps 5-HT polygenic risk interactions were not detected in predicting alcohol 
use in CDP because of the developmental timing of the alcohol use assessment (15-16 
years old). Indeed, some adolescents who were at genetic risk might not have had the 
opportunity to initiate alcohol use by that time. However, this hypothesis is speculative 
and the current data cannot inform the validity of this hypothesis. More work is needed to 
understand the direct effect of serotonin functioning on alcohol use in adolescence, 
especially after controlling for potential earlier mediating variables such as 
aggression/antisociality and depression.  
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Implications for Theory and Practice 
The present findings have several implications for theory and clinical practice. 
One important theoretical implication is in better understanding causes of co-occurrence. 
Indeed, research shows that depressive symptoms, aggression/antisociality, and alcohol 
use all co-occur with one another at a high rate (Bukstein, Brent, & Kaminer, 1989). 
Moreover, in both of the current samples the T2 and T3 measures of these problem 
behaviors were moderately-to-highly correlated.  
Several causes of co-occurrence have been outlined in the literature. First, some 
explanations for the observed rates of co-occurrence between disorders are artifactual. 
For instance, high rates of co-occurrence might be observed if only clinical samples are 
obtained, because these individuals are more likely to have multiple disorders (i.e., 
ascertainment bias). Co-occurrence could also be artifactually due to the presence of 
symptom overlap in the measurement of two disorders or could be due to random chance 
(Neale & Kendler, 1991). However, multiple previous studies have established that the 
observed co-occurrence between depressive symptoms and aggressive/antisocial 
behaviors, and between externalizing and internalizing disorders more broadly are not 
due to these factors (see Lilienfeld, 2003; Zoccolillo. 1992).  
There are also substantive reasons for co-occurrence. For example, psychological 
disorders might co-occur because they share the same underlying continuum of liability, 
their risk factors are correlated and/or shared, or one disorder causes the other disorder 
(i.e., direct causal model). Moreover, it is also possible that the co-occurring form is a 
third and separate disorder apart from pure forms or that the co-occurring form shares a 
similar etiology with one of the pure forms (Caron & Rutter, 1991; Neale & Kendler, 
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1995). Although the current study findings cannot determine the exact causes of co-
occurrence, they can point towards likely explanations to be followed up in future 
studies. 
The current finding that 5-HT polygenic risk and deficits in self-regulation 
predicted depression and aggression/antisociality across two samples provides evidence 
that these are shared risk factors that might account for the co-occurrence between these 
two problem behaviors. To illustrate, perhaps because deficits in self-regulation make it 
more difficult to inhibit negative affectivity, such as sadness and anger, this could result 
in the eventual manifestation of both depressive symptoms and aggressive/antisocial 
behaviors within the same individual. It is also possible that polygenic risk and self-
regulation are truly only risk factors for one of the two disorders, but are correlated with 
some other unmeasured risk factors that contribute to risk for the other disorder. For 
example, deficits in self-regulation are often correlated with poor social competence 
(Spinrad et al., 2007). Perhaps deficits in self-regulation contribute to the risk for 
aggression/antisociality only, and the correlated risk factor of poor social competence 
predicts depression within the same individual.  
The present findings are also in line with previous work suggesting that the co-
occurrence between depression and conduct problems is due, in part, to a common 
genetic liability (O’Connor, McGuire, Reiss, Hetherington, & Plomin, 1998; Rowe et al., 
2008; Subbarao et al., 2007). Specifically, results suggest that 5-HT polygenic risk might 
be one component that operates within this larger shared genetic risk liability. 
Interestingly, the present results also suggest that mechanisms of co-occurrence might 
vary depending on contextual factors. Indeed, our results suggested that 5-HT polygenic 
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risk and self-regulation might be stronger predictors of aggression/antisociality and 
depression at lower levels of SES. Thus, the extent to which these shared risk factors 
might contribute to the co-occurrence between these problem behaviors might be 
especially robust when SES is low.  
 There was less evidence that 5-HT polygenic risk and self-regulation were risk 
factors for alcohol use because these variables showed somewhat contradictory direct 
effects across the two samples in the current study. Thus, the co-occurrence of alcohol 
use with adolescents’ aggression/antisociality and depression might not be due these 
common risk factors. Instead, results suggested that aggression/antisociality might cause 
later alcohol use even after controlling for relevant covariates and earlier alcohol use. 
Thus, the direct causal model of co-occurrence could partially account for the co-
occurrence between aggression/antisociality and alcohol use. In contrast, the current data 
do not very clearly demonstrate why adolescents’ depressive symptom might co-occur 
with alcohol use.  
 These results also have implications for improving clinical practice. Given the 
transdiagnostic nature of deficient self-regulation, results suggest that intervention and/or 
prevention programs that target self-regulatory abilities will be helpful in reducing risk 
for depressive symptoms, aggressive/antisocial behaviors, and possibly their co-
occurrence. These types of programs might also exert downstream effects in reducing 
adolescents’ alcohol use and later disorder by curbing earlier aggression/antisociality. 
Consistent with this notion, prevention programs such as the PATHS curriculum (Riggs, 
Greenberg, Kusché, & Pentz, 2006) and the Rochester Resilience Project Intervention 
(Wyman et al., 2010) that are specifically designed to enhance self-control and emotion 
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regulation have demonstrated promising effects, including increasing children’s 
inhibitory control and reducing internalizing and externalizing behaviors. 
Similarly, results are consistent with previous work suggesting that medications 
used to alter serotonergic neurotransmission might reduce psychopathological symptoms. 
For example, Selective Serotonin Reuptake Inhibitors (SSRIs), which serve to increase 
the amount of serotonin available to bind to the postsynaptic receptor, are some of the 
most commonly prescribed medications to treat a variety of mental health issues. SSRIs 
have been shown to be effective in treating depression in children and adolescents, severe 
depression in adults, and impulsive aggression in adolescents and adults (Bond, 2005; 
Cherek, Lane, Pietras, & Steinberg, 2002; Kamarck et al., 2009; Kirsch, Deacon, Huedo-
Medina, Scoboria, Moore, & Johnson, 2008; Usala, Clavenna, Zuddas, Bonati, 2008). 
Studies also showed mild and transient effects of SSRIs in reducing alcohol consumption 
for moderate drinkers, but not for individuals with alcohol dependence (Litten et al., 
1996). 
Although very preliminary, it is possible that the methods and ideas used to create 
the current polygenic risk scores could have clinical utility, especially because they 
demonstrated predictive validity and replicability across studies. Perhaps more well-
refined and comprehensive polygenic risk scores indexing serotonergic functioning could 
be used to identify individuals who would benefit the most from SSRI treatments. Indeed, 
because SSRIs lead to initial increases in serotonin neurotransmission, perhaps they 
would be the most effective for individuals with genetic risk for lower baseline 
serotonergic functioning.  
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Finally, findings contribute to current efforts aligned with the Alcohol Addiction 
Research Domain Criteria (AARDoC; Litten et al., 2015). The AARDoC seeks to better 
understand the considerable heterogeneity in the presentation and etiology of alcohol use 
disorders across individuals. To do so, AARDoC calls for future research to investigate 
whether several broader domains of functioning, such as reward, stress and affect 
regulation, incentive salience, executive function, and social processes, might 
differentiate among individuals with alcohol use disorder and subsequently inform the 
application of differential treatments. Moreover, this framework calls for an integration 
of multiple levels of analysis to understand these broad domains, including genetics, 
neuroscience, physiology, and behavior. 
Although preliminary, our results suggest that serotonergic functioning might not 
play a role in an executive functioning domain due to its lack of association with effortful 
control/conscientiousness, whose definitions overlap with executive functioning. Because 
aggression/antisociality mediated the relation between polygenic risk and alcohol use in 
the current study, the present results also call for future research that examines whether 5-
HT polygenic risk might be involved in other broader domains related to aggression and 
delinquency, such as incentive salience or reward pathways. This could help to identify 
the domain (i.e., dysregulated incentive salience or reward) that would require the most 
attention in treatment for individuals with lower levels of serotonergic functioning, and 
this biological phenotype might act as an early identification factor for at-risk individuals 
as well.  
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Strengths and Limitations 
 The current study had several limitations that should be noted. First, as stated 
earlier, the polygenic risk scores created in this study only contained 23 SNPs. Without a 
doubt, many more genetic variants and genomic processes are involved in serotonergic 
functioning that we were unable to include in this score. Future studies that create 
polygenic risk scores might consider including more SNPs as well as other forms of 
genetic variation, such as insertions/deletions and variable number tandem repeats. 
Similarly, it would be very informative for future studies to examine other genetic 
processes to gain the most comprehensive picture of genetic risk for serotonergic deficits, 
such as epigenetic mechanisms, functional human nonprotein-coding RNAs, and rare 
variants. Additionally, neither study used in these analyses collected measures of 
serotonergic functioning. Thus, we were unable to confirm whether the polygenic risk 
scores created to index serotonergic functioning actually captured the intended construct. 
A measure of serotonergic functioning would also have been useful to include in the 
longitudinal models. Doing so could have provided even more robust evidence that 
serotonergic functioning is a mechanism that underlies risk pathways to adolescents’ 
alcohol use.  
Relatedly, it will be important for future studies with larger sample sizes to 
replicate the effects found in this study. Both of the samples used in this study were only 
powered to detect between small and moderate effect sizes separately for boys and girls 
(the only hypothesized moderator in the study). Thus, the current samples were 
underpowered to detect small polygenic risk effects that differed by one or more 
moderating variables. The samples were also limited to adolescents who self-reported 
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their ethnicity to be non-Hispanic Caucasian. Although this was advantageous for several 
reasons (see below), it also does not address the important question of whether the same 
risk processes operate in individuals from other ethnic groups. This limits the 
generalizability of the findings and limits the advancement of knowledge and research 
with minority groups.   
 Another limitation of the study was the heavy reliance on adolescents’ self-report 
data. Variables in the CDP model were all self-reported by adolescents except for 
polygenic risk. The same is true for AFDP, except that effortful control was a multi-
reporter construct. Although adolescents’ self-reports of depression, 
aggression/antisociality, and alcohol use are likely more reliable and accurate than reports 
made by parents (e.g., Grills & Ollendick, 2002), perhaps also including peer ratings of 
these constructs (particularly alcohol use) could have increased confidence in the 
findings. However, peer-reports of adolescents’ symptoms were not available in either 
study.  
 The AFDP and CDP samples and measures were also different in several ways, 
which could be viewed as a limitation. For example, the AFDP sample had considerably 
greater age heterogeneity than the CDP. Thus, even though the mean ages at each time 
point were somewhat similar across samples, the age ranges were quite discrepant. Given 
that the effects of problem behaviors and temperament on alcohol use are 
developmentally sensitive, the differences in ages across samples could have accounted 
for the non-replication of certain paths across models. Similarly, AFDP is a high-risk 
sample whereas CDP is a community sample and we did not have the exact same 
measures across both studies. These factors also might have rendered replication more 
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difficult. On the other hand, Rosenbaum (2001) suggested that observing similar 
phenomena across different situations (i.e., replication in samples that differ) might 
provide even stronger evidence that the phenomena observed are real. Indeed, 
discovering the same effects across different situations helps to eliminate the possibility 
that the same third variable is causing spurious relations. Because of the differences 
between studies, the findings that were replicated across studies might be even more 
trustworthy. Thus, the presence of differences across studies has both advantages and 
disadvantages.  
 The current study also had several strengths that increase confidence in the 
findings. The 5-HT polygenic risk scores were created using GWAS results from an 
independent sample (Luykx et al., 2014). We were able to test and replicate the results 
from this work in two independent, longitudinal samples of adolescents. Using this 
approach yielded some consistent polygenic risk effects across the two studies. This is 
noteworthy in light of the replication difficulties that have challenged the genetic 
literature (Plomin et al., 2016). Similarly, it was a major strength of the study to have two 
very well characterized longitudinal samples of adolescents with good measurement of 
adolescents’ problem behaviors and relevant demographic and environmental 
information. Thus, in both studies, adolescents’ problem behaviors were assessed using 
well-validated and reliable measures and several potential confounding variables were 
controlled for, therefore increasing confidence in the present findings.  
 Another strength of the study was the focus on capturing genetic risk for an 
endophenotype of alcohol use risk. This methodology provided insight into the 
mechanisms underlying risk for alcohol use in adolescence. It is also more in line with 
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current efforts to advance personalized treatment of alcohol use disorders by 
understanding the unique biological and behavioral mechanisms of the disorder (e.g., 
AARDoC; Litten et al., 2015). The 5-HT polygenic risk scores also demonstrated 
predictive validity. Although it was not possible to test associations with serotonergic 
functioning, the5-HT polygenic risk scores related with constructs expected to be related 
to serotonergic functioning, such as aggression/antisociality, depression, and alcohol use. 
By including only non-Hispanic Caucasian adolescents, it was less likely that population 
stratification accounted for the results. Moreover, it was important to choose this 
subgroup because the independent GWAS was performed with European participants 
and, therefore, at least some of the genetic risk variants identified might be most salient 
for Caucasian populations.  
 A major strength of this study was the use of baseline measures of 
psychopathology and alcohol use as covariates so that analyses were prospective. For 
instance, it was possible to establish that T3 aggression/antisociality predicted change in 
alcohol use from T3-T4 in both studies, and that this relation was not spuriously caused 
by the concurrent association between T3 alcohol use and aggression.  
Conclusion 
 The current study provided several insights into developmental risk pathways for 
alcohol use and other problem behaviors. This study found robust evidence that 
aggression/antisociality is one mechanism that underlies the well-established association 
between serotonergic functioning and alcohol consumption. This pathway might be 
especially salient for boys from economically disadvantaged homes. This study also 
provided evidence to suggest that individuals with lower levels of serotonin functioning 
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might not be predisposed towards deficits in effortful control/conscientiousness. 
Therefore, self-regulation is likely not the mechanism through which serotonergic 
functioning exerts risk for multiple different types of psychopathology. 5-HT polygenic 
risk scores and effortful control/conscientiousness were both risk factors for later 
aggression/antisociality, depression, and alcohol use (either for certain subgroups or 
indirectly). This suggests that these two constructs are very good candidates for future 
work on transdiagnostic risk factors. Clarifying the common and unique roles that these 
more basic risk factors play in psychopathology could aid in the creation of better 
diagnostic tools, advance our understanding of the etiology of psychopathology, and 
greatly enhance prevention and intervention efforts. 
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Table 1 
Descriptive Statistics for Study Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. N = 254 for AFDP and N = 348 for CDP.  Descriptive statistics for AFDP presented outside of parentheses and descriptive statistics for CDP presented in 
parentheses. Values of “n/a” indicate that this variable was not assessed in that particular sample or that they are not relevant.  aThe SES variable used for AFDP 
and CDP is the highest level of parental education bA continuous measure of parents’ lifetime alcohol problems was used for CDP analyses whereas a 
dichotomous measure of parents’ lifetime diagnosis of alcohol or drug dependence was used for AFDP analyses.  cAFDP assessed effortful control at T1 whereas 
CDP assessed conscientiousness at T1.  
 
Continuous/Count Variables Mean SD Min. Max. Skewness Kurtosis 
T1 Age 12.40 (12.5) 1.66 (n/a) 10.02 (n/a) 17.27 (n/a) 0.76 (n/a) -0.50 (n/a) 
T2 Age 13.65 (14.5) 1.75 (n/a) 11.01 (n/a) 18.89 (n/a) 0.80 (n/a) -0.30 (n/a) 
T3 Age 16.69 (15.5) 2.09 (n/a) 13.14 (n/a) 20.95 (n/a) 0.18 (n/a) -1.05 (n/a) 
SESa 7.50 (5.27) 2.25 (1.20) 1.00 (2.00) 11.00 (7.00) -0.58 (-0.06) 0.19 (-1.05) 
Parents’ Alcohol Problemsb n/a   (0.98) n/a   (1.71) n/a   (0.00) n/a    (12.00) n/a    (3.26) n/a   (14.35) 
Ancestry Factor Scores 0.54 (n/a) 0.33 (n/a) -1.00 (n/a) 1.32 (n/a) -0.78 (n/a) 1.80 (n/a) 
Time between T1 and T2  1.27 (n/a) 0.38 (n/a) 0.10 (n/a) 3.40 (n/a) 2.95 (n/a) 11.75 (n/a) 
Time between T2 and T3  2.85 (n/a) 1.04 (n/a) 0.52 (n/a) 4.64 (n/a) -0.30 (n/a) -0.88 (n/a) 
Polygenic Risk Score 0.40 (0.46) 0.30 (0.30) -0.36 (-0.44) 1.37 (1.47) 0.28 (0.08) 0.48 (0.43) 
T1 Effortful Control (Conscientiousness)c 0.00 (3.49) 0.57 (0.63) -1.54 (1.20) 1.31 (5.00) 0.09 (-0.21) -0.57 (0.34) 
T1 Aggressive/Antisocial Behavior 2.09 (2.40) 2.97 (2.49) 0.00 (0.00) 17.00 (13.00) 2.05 (1.26) 4.73 (1.33) 
T1 Depressive Symptoms 3.01 (3.70) 3.25 (2.76) 0.00 (0.00) 22.00 (12.00) 2.10 (0.81) 6.32 (0.27) 
T2 Aggressive/Antisocial Behavior 1.86 (2.73) 2.93 (2.93) 0.00 (0.00) 18.00 (23.00) 2.56 (2.29) 7.93 (9.69) 
T2 Depressive Symptoms 2.39 (3.56) 3.21 (3.40) 0.00 (0.00) 21.00 (16.00) 2.49 (1.24) 8.84 (1.43) 
T2 Alcohol Use 0.23 (0.28) 0.80 (0.65) 0.00 (0.00) 4.00 (4.00) 3.68 (2.87) 12.96 (9.55) 
T3 Alcohol Use 0.74 (0.51) 1.48 (0.87) 0.00 (0.00) 7.00 (4.00) 2.00 (1.91) 3.03 (3.52) 
Dichotomous Variables       
Gender 51.5% males (47.9% males) 
48.5% females (52.1% females) 
Parents’ SUDb 45.1% no parent with SUD (n/a) 
54.9% parent with SUD (n/a) 
Medication Use 84.3% do not use prescription medications (n/a) 
14.7% do use prescription medications (n/a) 
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Table 2 
 
Zero-Order Correlations Among AFDP Study Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. †p ≤ 0.10. *p ≤ 0.05. **p ≤ 0.01. N = 254. Higher scores on the Polygenic Risk Score represent lower concentrations of CSF 5-HIAA. Gender is coded 0 
for Females and 1 for Males. Parents’ Substance Use Disorder is coded 0 for parents without SUD and 1 for parents with SUD. Higher levels of ancestry indicate 
greater levels of Caucasian ancestry. Higher levels of all other variables indicate higher levels of the construct. 
 
 
 
 
 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 
1. Polygenic Risk Score 1                
2. Gender  -0.11† 1               
3. SES -0.01 0.07 1              
4. Parents’ Substance Use 
Disorder 
0.01 -0.15*  -0.23** 1   
   
       
5. Ancestry -0.09 0.02 0.10 -0.08 1            
6. Age   0.14* -0.06 0.01 0.10  -0.18** 1           
7. Prescription Medication Use -0.01  0.11† 0.03 0.09 -0.12†   0.10 1          
8. Time between T1 and T2 -0.02 -0.02 -0.04 0.10   -0.01 0.17*   0.02 1         
9. Time between T2 and T3   0.17* -0.15*  0.07   0.003   -0.06  0.23**   0.06  -0.36** 1        
10. Effortful Control -0.03  -0.16**   0.004 -0.12* 0.03  -0.05  -0.25**  -0.05  0.01 1       
11. T1 Aggressive/Antisocial 
Behaviors 
  0.12† 0.10  -0.12†  0.13* -0.14*  0.33**  0.32**   0.01  0.09 -0.40** 1      
12. T1 Depressive Symptoms 0.06 -0.04 -0.01 0.10   -0.06 0.15*  0.29**  -0.07 0.16* -0.32** 0.64** 1     
13. T2 Aggressive/Antisocial 
Behaviors 
  0.20** 0.04 -0.09   0.20**  -0.18**  0.27**  0.33**  -0.02 0.17* -0.37** 0.66** 0.53** 1    
14. T2 Depressive Symptoms   0.24** -0.15* -0.03   0.20**   -0.08  0.17**  0.26**  -0.03 0.17* -0.26** 0.38** 0.56** 0.68** 1   
15. T2 Alcohol Use   0.28** -0.09   -0.14*  0.16*  -0.19**  0.29**  0.14*  0.11†  0.09 -0.23** 0.46** 0.28** 0.55** 0.28** 1  
16. T3 Alcohol Use   0.35** -0.04 -0.03 0.02  -0.19**  0.35**  0.14* 0.06 0.25** -0.18** 0.45** 0.16* 0.34** 0.22**  0.43** 1 
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Table 3 
Zero-Order Correlations Among CDP Study Variables 
 
 
 
 
 
 
 
 
 
 
 
 
Note. †p ≤ 0.10. *p ≤ 0.05. **p ≤ 0.01. N = 348. Higher scores on the Polygenic Risk Score represent lower concentrations of CSF 5-
HIAA. Gender is coded 0 for Females and 1 for Males. Higher levels of all other variables indicate higher levels of the construct. 
 
 
 
 
 
 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 
1. Polygenic Risk Score 1           
2. Gender -0.003 1          
3. SES 0.03   0.10 1         
4. Parents’ Alcohol Problems -0.02  -0.03 -0.10† 1        
5. T1 Conscientiousness -0.03 -0.13* -0.004 -0.02 1       
6. T1 Aggressive/Antisocial Behavior 0.10†  0.16* -0.09 0.16*  -0.14* 1      
7. T1 Depressive Symptoms 0.09 -0.12† -0.04 0.04 -0.17** 0.35** 1     
8. T2 Aggressive/Antisocial Behavior -0.01 0.13* -0.06 0.01  -0.12†  0.36** 0.15* 1    
9. T2 Depressive Symptoms 0.06 -0.21** -0.08 0.04 -0.17** 0.13*  0.46** 0.43** 1   
10. T2 Alcohol Use -0.03   0.00  0.01 -0.03  -0.03  0.20**  0.05 0.47**  0.18** 1  
11. T3 Alcohol Use -0.12* -0.10†  0.09 0.11†   0.01  0.06  0.03 0.28**  0.15* 0.37** 1 
      
 96  
Table 4 
Single Nucleotide Polymorphisms (SNPs) Included in the AFDP and CDP Polygenic Risk 
Scores 
SNP Gene p-valuea 
rs4863731 MAML3 0.001815 
rs1544623 NRXN3 0.003153 
rs9847748 FAM19A4 0.003487 
rs5753625 EIF4ENIF1 0.01117 
rs7219247 GRIN2C 0.01206 
rs6494212 CHRNA7 0.01219 
rs2823662 MIR99AHG 0.01595 
rs4953262 PRKCE 0.01805 
rs135757 CSNK1E 0.0192 
rs636842 AVEN 0.0192 
rs2611605 CHRNA7 0.01929 
rs1799971 OPRM1 0.0225 
rs760288 NRXN3 0.02268 
rs2236256 IPFCEF1 0.02273 
rs2272381 OPRM1 0.02965 
rs1931059 DLGAP3 0.03011 
rs782444 MGLL 0.03569 
rs1869237 NRP1 0.03846 
rs10213647 NPY2R 0.04387 
rs4782262 GRIN2A 0.04626 
rs1861957 NRXN3 0.04736 
rs1426223 GABRB3 0.04805 
rs1151523 FOSL1 0.04948 
Note. aThe p-value of each SNP in the discovery GWAS (i.e., Luykx et al., 2014). 
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Table 5 
Comparison of the Relative Model Fit Indices to Determine the Appropriate Modeling 
Strategy for Alcohol Use Outcomes 
 AFDP Alcohol Use Outcome 
 Categorical Continuous Zero-Inflated 
Negative 
Binomial 
Zero-
Inflated 
Poisson 
Akaike Information Criteria  3357.05  3684.53  3388.92  3392.03 
Bayesian Information Criteria  3470.24  3780.04  3487.97  3487.54 
Loglikelihood -1646.52 -1815.27 -1666.46 -1669.02 
 CDP Alcohol Use Outcome 
 Categorical Continuous Zero-Inflated 
Negative 
Binomial 
Zero-
Inflated 
Poisson 
Akaike Information Criteria  3669.14  3841.41  3878.43  3876.42 
Bayesian Information Criteria  3711.45  3876.03  3916.89  3911.04 
Loglikelihood -1823.57 -1911.71 -1929.21 -1929.21 
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Table 6 
AFDP Final Model 
 Outcomes 
 First Block 
 
T1 Effortful 
Control 
T2 
Depressive 
Symptoms 
T2 
Aggressive/ 
Antisocial 
Behaviors 
T3 Alcohol Use 
Predictors β(SE) β(SE) β(SE) β(SE)           OR 
Ancestry -0.01(0.06) -0.01(0.07) -0.07(0.07) -0.05(0.07)    0.66 
Gender -0.16(0.05)** -0.13(0.06)* -0.03(0.04) -0.04(0.08)    0.80 
Age -0.02(0.07)  0.04(0.07)  0.04(0.06)  0.31(0.08)** 1.62 
Parents’ SUD -0.13(0.06)*  0.12(0.06)*  0.10(0.04)*  0.16(0.09)†  2.27 
Parents’ Education -0.003(0.08)  0.03(0.04) -0.01(0.04) -0.15(0.09)  0.84 
Prescription 
Medication Use 
-0.22(0.06)**  0.12(0.05)*  0.11(0.07) †  0.01(0.08) 0.09 
Time 1Time 2 -- -0.02(0.03) -0.04(0.03) -- -- 
Time 2Time 3 -- -- --  0.22(0.08)* 1.71 
Polygenic Risk Score -0.05(0.06)  0.19(0.05)**  0.11(0.05)*  0.24(0.09)*   8.06 
T1 Effortful Control -- -0.09(0.04)* -0.10(0.04)* -0.06(0.09)     0.75 
T1 Depressive 
Symptoms 
--  0.42(0.08)** -- -- -- 
T1 Aggressive/ 
Antisocial Behaviors 
-- -- 0.53(0.06)** -- -- 
T2 Depressive 
Symptoms 
-- -- -- -0.17(0.13) 0.87 
T2 Aggressive/ 
Antisocial Behaviors 
-- -- --  0.23(0.09)* 1.23 
T2 Alcohol Use -- -- --  0.11(0.11) 1.42 
 Second Block 
T2 Depression-by-
SES 
-- -- --  0.16(0.05)* -- 
T2 Depression-by-
Ancestry 
-- -- --  0.14(0.05)* -- 
Note. †p ≤ 0.10. *p ≤ 0.05. **p ≤ 0.01. N = 254. Higher scores on the Polygenic Risk 
Score represent lower concentrations of CSF 5-HIAA. Gender is coded 0 for Females and 
1 for Males. Parents’ SUD is coded 0 for parents without SUD and 1 for parents with 
SUD. Higher levels of ancestry indicate greater levels of Caucasian ancestry. Higher 
levels of all other variables indicate higher levels of the construct. 
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Table 7 
CDP Final Model 
 Outcomes 
 First Block 
 
T1 
Conscientiousness 
T2 
Depressive 
Symptoms 
T2 
Aggressive/ 
Antisocial 
Behaviors 
T3 Alcohol Use 
Predictors β(SE) β(SE) β(SE) β(SE)           OR 
Gender  -0.13(0.06)*  -0.17(0.06)*  0.06(0.06) -0.18(0.08)*  0.49 
Parents’ Education   0.01(0.06)  -0.04(0.05) -0.02(0.06)  0.17(0.07)*  1.33 
Parents’ Alcohol 
Problems 
 -0.02(0.09)   0.01(0.05) -0.04(0.05)  0.13(0.07)*  1.17 
Polygenic Risk Score  -0.03(0.06)   0.02(0.05) -0.02(0.05) -0.12(0.07)†  0.43 
T1 Conscientiousness --  -0.12(0.05)* -0.05(0.05) -0.02(0.06)  0.95 
T1 Depressive 
Symptoms 
--   0.40(0.05)** -- -- -- 
T1 Aggressive/ 
Antisocial Behaviors 
-- --  0.34(0.07)** -- -- 
T2 Depressive 
Symptoms 
-- -- --  0.03(0.08)  1.02 
T2 Aggressive/ 
Antisocial Behaviors 
-- -- --  0.11(0.12)  1.08 
T2 Alcohol Use -- -- --  0.31(0.08)**  2.61 
 Second Block 
Polygenic Risk-by- 
SES 
-- -0.15(0.05)** -0.18(0.05)** -- -- 
Polygenic Risk-by- 
Gender 
--  0.03(0.06)  0.04(0.06) -- -- 
Polygenic Risk-by- 
Parents’ Alcohol 
Problems 
-- -0.06(0.06) -0.07(0.05) -- -- 
SES-by-Gender -- -0.02(0.05) -0.03(0.06) -- -- 
SES-by-Parents’ 
Alcohol Problems 
-- -0.02(0.08)  0.04(0.05) -- -- 
Conscientiousness-
by-SES 
--  0.18(0.05)**  0.11(0.04)* -- -- 
T2 Depression-by-
Gender 
-- -- -- -0.17(0.08)* -- 
T2 Aggressive/ 
Antisocial-by-Gender 
-- -- --  0.20(0.09)* -- 
Note. †p ≤ 0.10. *p ≤ 0.05. **p ≤ 0.001. N = 348. Higher scores on the Polygenic Risk Score represent 
lower concentrations of CSF 5-HIAA. Gender is coded 0 for Females and 1 for Males. Higher levels of all 
other variables indicate higher levels of the construct. Gray text refers to interaction terms included based 
on recommendations by Keller (2014).   
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Table 8 
Moderated Mediation Coefficients for AFDP Model 
Note. †p < 0.10. *p < 0.05. **p < 0.001. N = 254. Standardized regression coefficients are 
shown. Standard errors are shown in parentheses. Low, mean and high SES and ancestry 
refer to 1 SD below the mean, at the mean, and 1 SD above the mean of SES and 
ancestry, respectively. Bolded terms refer to a significant mediated effect.  
  
 Mediational Chain 
Combinations of 
Moderators 
Polygenic RiskDepressive SymptomsAlcohol 
Use 
 a b 
Low Levels of SES 0.15(0.06)* -0.39(0.11)** 
Mean Levels of SES 0.19(0.05)** -0.22(0.08)* 
High Levels of SES 0.23(0.07)** -0.03(0.08) 
Low Levels of Ancestry 0.16(0.06)* -0.32(0.09)** 
Mean Levels of Ancestry 0.20(0.06)* -0.22(0.08)* 
High Levels of Ancestry 0.24(0.08)** -0.12(0.08) 
 
Effortful ControlDepressive SymptomsAlcohol 
Use 
 a b 
Low Levels of SES -0.13(0.06)* -0.39(0.11)** 
Mean Levels of SES -0.10(0.04)* -0.22(0.08)* 
High Levels of SES -0.09(0.05)†  -0.03(0.08) 
Low Levels of Ancestry -0.08(0.07) -0.32(0.09)** 
Mean Levels of Ancestry -0.10(0.04)* -0.22(0.08)* 
High Levels of Ancestry  -0.11(0.06)* -0.12(0.08) 
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Table 9  
Moderated Mediation Coefficients for CDP Model 
Note. †p < 0.10. *p < 0.05. N = 348. Standardized regression coefficients are shown. 
Standard errors are shown in parentheses. Low, mean and high SES refer to 1 SD below 
the mean, at the mean, and 1 SD above the mean of SES, respectively. Bolded terms refer 
to a significant mediated effect.  
  
 Mediational Chain 
 Polygenic RiskAggressive/AntisocialAlcohol Use 
Combinations of Moderators a b 
Females with Low SES  0.13(0.09) -0.02(0.16) 
Females with Mean SES -0.05(0.09) -0.05(0.12) 
Females with High SES -0.24(0.12)* -0.08(0.13) 
Males with Low SES  0.21(0.09)*  0.35(0.15)* 
Males with Mean SES  0.03(0.06)  0.34(0.13)* 
Males with High SES -0.15(0.07)*  0.31(0.14)* 
 Polygenic RiskDepressive SymptomsAlcohol Use 
 a b 
Females with Low SES  0.14(0.09)  0.16(0.11) 
Females with Mean SES -0.01(0.09)  0.16(0.09)† 
Females with High SES -0.18(0.11)†  0.16(0.14) 
Males with Low SES  0.23(0.08)* -0.19(0.15) 
Males with Mean SES  0.07(0.06) -0.17(0.15) 
Males with High SES -0.09(0.06) -0.19(0.19) 
 ConscientiousnessAggressive/AntisocialAlcohol Use 
 a b 
Females with Low SES -0.12(0.08) -0.02(0.16) 
Females with Mean SES -0.05(0.06) -0.05(0.12) 
Females with High SES  0.05(0.05) -0.08(0.13) 
Males with Low SES -0.17(0.07)*  0.35(0.15)* 
Males with Mean SES -0.10(0.06)  0.34(0.13)* 
Males with High SES  -0.01(0.07)  0.31(0.14)* 
 ConscientiousnessDepressive SymptomsAlcohol Use 
 a b 
Females with Low SES -0.32(0.09)**  0.16(0.11) 
Females with Mean SES -0.21(0.08)*  0.16(0.09)† 
Females with High SES -0.04(0.10)  0.16(0.14) 
Males with Low SES -0.24(0.07)** -0.19(0.15) 
Males with Mean SES -0.10(0.05)† -0.17(0.15) 
Males with High SES  0.08(0.06) -0.19(0.19) 
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Table 10 
Side-by-Side Comparison of AFDP and CDP Main Paths of Interest  
Note. aSelf-regulation refers to effortful control in AFDP and to conscientiousness in 
CDP. Bolded text in black print refers to effects that were replicated in both studies. ‘+’ 
indicates that the effect is positive. ‘-‘ indicates that the effect is negative. ‘ns’ indicates 
that the effect is not statistically significant. Gray text refers to effects that were not 
replicated across studies.  
 
  
 
 AFDP CDP 
Polygenic Risk  Self-Regulationa ns ns  
Polygenic Risk  Depression + +  (at low SES) 
-   (at high SES) 
Polygenic Risk  Aggression/Antisociality + +  (at low SES) 
-   (at high SES) 
Polygenic Risk  Alcohol Use + -  (marginal) 
Self-Regulation  Depression 
- -   (at low and mean SES) 
ns  (at high SES) 
Self-Regulation  Aggression/Antisociality 
- -  (at low SES) 
Self-Regulation  Alcohol Use ns ns 
Depression  Alcohol Use 
- (low and mean SES and 
ancestry) 
+ (marginally for girls) 
Aggression/Antisociality Alcohol Use + + (for boys) 
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Figure 1. Hypothesized Model. For AFDP, Time 1 = 10-17.99 years old, Time 2 = 11-18.99 years old, and Time 3 = 13-20.99 years 
old. For CDP, Time 1 = 12-13 years old, Time 2 = 14-15 years old, and Time 3 = 15-16 years old. For CDP, a measure of 
conscientiousness was used to reflect effortful control. Gray boxes and lines: baseline control variables. All other covariates not shown 
for ease of presentation. Correlations were estimated among all exogenous variables, among T1 depressive symptoms, 
aggressive/antisocial behaviors and effortful control/conscientiousness, and among T2 depressive symptoms, aggressive/antisocial 
behaviors and alcohol use (not shown here). Refer to Methods section for more details about the structural equation modeling.  
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Figure 2. Visual Display of the AFDP Data Collection Timeline. G1: Generation 1. G2: Generation 2. G3: Generation 3.  
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Figure 3. AFDP Final Path Model. †p < 0.10. *p < 0.05.  N = 254. Time 1 = 10-17.99 years old, Time 2 = 11-18.99 years old, and 
Time 3 = 13-20.99 years old. Grayed lines: non-significant paths. Black lines: significant or marginally significant paths. Bolded lines: 
paths involved in significant mediated effects. All other covariates not shown for ease of presentation. Correlations were estimated 
among all exogenous variables, among T1 depressive symptoms, aggressive/antisocial behaviors and effortful control, and among T2 
depressive symptoms, aggressive/antisocial behaviors and alcohol use (not shown here). 5-HT Polygenic Risk Score coded such that 
higher scores represent lower levels of CSF 5-HIAA (i.e., lower levels of serotonin functioning). 
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Figure 4. CDP Final Path Model. †p < 0.10. *p < 0.05. **p < 0.001. N = 348. Time 1 = 12-13 years old, Time 2 = 14-15 years old, and 
Time 3 = 15-16 years old. Grayed lines: non-significant paths. Black lines: significant or marginally significant paths. All other 
covariates not shown for ease of presentation. Bolded lines: paths involved in significant mediated effects. Correlations were 
estimated among all exogenous variables, among T1 depressive symptoms, aggressive/antisocial behaviors and conscientiousness, and 
among T2 depressive symptoms, aggressive/antisocial behaviors and alcohol use (not shown here). 5-HT Polygenic Risk Score coded 
such that higher scores represent lower levels of CSF 5-HIAA (i.e., lower levels of serotonin functioning).
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Figure 5. AFDP Interaction between Depressive Symptoms and Socioeconomic Status in Predicting Alcohol Use.  Black lines 
indicate statistically significant simple slopes. Slopes probed at low and average levels of socioeconomic status are statistically 
significant. Simple slopes represent combinations of socioeconomic status and depressive symptoms that actually exist in the data.
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Figure 6. AFDP Interaction between Depressive Symptoms and Ancestry in Predicting Alcohol Use.  Black lines indicate statistically 
significant simple slopes. Slopes probed at low and average levels of ancestry are statistically significant. Simple slopes represent 
combinations of ancestry and depressive symptoms that actually exist in the data. 
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Figure 7. CDP Interaction between Polygenic Risk and Socioeconomic Status in Predicting Aggressive/Antisocial Behaviors. Black 
lines indicate statistically significant simple slopes. Slopes probed at low and high levels of socioeconomic status are statistically 
significant. Simple slopes represent combinations of socioeconomic status and polygenic risk that actually exist in the data. 
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Figure 8. CDP Interaction between Conscientiousness and Socioeconomic Status in Predicting Aggressive/Antisocial Behaviors.  
Black lines indicate statistically significant simple slopes. Slope probed at low levels of socioeconomic status are statistically 
significant. Simple slopes represent combinations of socioeconomic status and conscientiousness that actually exist in the data. 
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Figure 9. CDP Interaction between Polygenic Risk and Socioeconomic Status in Predicting Depressive Symptoms.  Black lines 
indicate statistically significant simple slopes. Slopes probed at low and high levels of socioeconomic status are statistically 
significant. Simple slopes represent combinations of socioeconomic status and polygenic risk that actually exist in the data. 
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Figure 10. CDP Interaction between Conscientiousness and Socioeconomic Status in Predicting Depressive Symptoms.  Black lines 
indicate statistically significant simple slopes. Slopes probed at low and mean levels of socioeconomic status are statistically 
significant. Simple slopes represent combinations of socioeconomic status and conscientiousness that actually exist in the data. 
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Figure 11. CDP Interaction between Aggressive/Antisocial Behaviors and Gender in Predicting Alcohol Use.  Black line indicates 
statistically significant simple slope. The simple slope for males is statistically significant.  Simple slopes represent values of 
aggressive/antisocial behaviors that actually exist in the data for males or for females. 
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Figure 12. CDP Interaction between Depressive Symptoms and Gender in Predicting Alcohol Use.  Black line indicates statistically 
significant simple slope. The simple slope for females is statistically significant. Simple slopes represent values of depressive 
symptoms that actually exist in the data for males or for females. 
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AFDP EFFORTFUL CONTROL ITEMS  
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Inhibitory Control  
1. It’s hard for me not to open presents before I’m supposed to.   
2. When someone tells me to stop doing something, it is easy for me to stop.   
3. The more I try to stop myself from doing something I shouldn’t, the more likely I 
am to do it.    
4. It’s easy for me to keep a secret.   
5. I can stick with my plans and goals.    
Attentional Control  
1. It is easy for me to really concentrate on homework problems.    
2. I find it hard to shift gears when I go from one class to another at school.  
3. When trying to study, I have difficulty tuning out background noise and 
concentrating.    
4. I am good at keeping track of several different things that are happening around 
me.    
5. I pay close attention when someone tells me how to do something.    
6. I tend to get in the middle of one thing, then go off and do something else.   
Activation Control  
1. I have a hard time finishing things on time.   
2. I do something fun for awhile before starting my homework, even when I’m not 
supposed to.    
3. If I have a hard assignment to do, I get started right away.    
4. I finish my homework before the due date.    
5. I put off working on projects until right before they’re due.   
Note. These items were the same for parents but instead of the stem “I...” the stem was 
“[Child’s Name]…” 
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CDP CONSCIENTIOUSNESS ITEMS  
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1. How organized do you think you are?  
2. How lazy do you think you are? (reverse)  
3. Some kids are very responsible, they can be counted on to do what they are told to 
do, but other kids are not very responsible, they often do not remember what they 
were told to do. How responsible do you think you are?  
4. How neat do you think you are about your things?  
5. How forgetful do you think you are? (reverse) 
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APPENDIX C  
AFDP AND CDP SYMPTOMATOLOGY ITEMS  
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DSM-Oriented Affective Problems 
1. There is very little that I enjoy 
2. I cry a lot 
3. I deliberately try to hurt or kill myself 
4. I don’t eat as well as I should  
5. I feel worthless or inferior 
6. I feel too guilty 
7. I feel overtired without good reason 
8. I sleep less than most kids 
9. I sleep more than most kids during the day and/or at night 
10. I think about killing myself 
11. I have trouble sleeping 
12. I am unhappy, sad, or depressed 
13. I don’t have much energy 
DSM-Oriented Conduct Problems 
1. I am mean to others 
2. I destroy things belonging to others 
3. I don’t feel guilty after doing something I shouldn’t 
4. I break rules at home, school, or elsewhere 
5. I get in many fights 
6. I hang around with kids who get in trouble 
7. I lie or cheat 
8. I physically attack people 
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9. I run away from home 
10. I set fires 
11. I steal at home 
12. I steal from places other than home 
13. I swear or use dirty language 
14. I threaten to hurt people 
15. I cut classes or skip school 
 
 
